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INTRODUCTION 
 
 Genital ulcer is defined as the breach in the genital mucosa and or the skin. 
Genital ulcer disease constitutes about 1% to 70% of the sexually transmitted 
diseases in various parts of the world¹. The incidence of genital ulcer disease 
varies from region to region, influenced by the variation in the prevalence of 
causative agents, sociocultural factors, the sexual behavior of the population, 
economy and civilization.  
 
 In the whites and in developed countries, herpetic ulcers are common. In 
Blacks and Hispanics, syphilis and chancroid are common. In developing 
countries chancroid is common .In both developing and industrialized countries of 
the world, syphilis is common². In some parts of Asia, most importantly South 
India, Donovanosis is seen.3 Various studies in India show a rise in the incidence 
of herpes,  and in some studies, the prevalence of herpes has exceeded the 
prevalence of syphilis and chancroid.4-6  
 
 Genital ulcers are frequently reported in men,  as they are easily  detected 
in males compared to females. Males act as the reservoir of infection constantly 
infecting the male and the female population. Genital ulcers which are 
symptomatic have an equal incidence in males and females, whereas those which 
are asymptomatic are under reported in females.  
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 Females with asymptomatic genital ulcers are the reservoir of infection and 
they form a significant risk group infecting male partners.2 Due to the increasing 
coinfection with HIV and mixed infections, the morphology of the genital ulcers 
are altered and the prototypical description of the ulcers may not be present.7 A 
secondarily infected syphilitic chancre can mimic chancroid, and herpes and 
chancroid coinfection may cause diagnostic difficulties.  
  
 The ulcers be confined to genitalia or may be found in the extragenital sites 
because of changes in the sexual behavioural pattern. Due to the self medication 
or the contamination of the ulcers, the demonstration of the etiological agents 
causing the ulcer becomes difficult. In case of early lesions, the bedside and 
laboratory investigations are fairly sensitive and specific.2 
  
Review of Literature 
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REVIEW OF LITERATURE 
 
Etiological classification of genital ulcer disease8 
 Genital ulcers can be due to venereal diseases more commonly and rarely 
due to other dermatological or systemic conditions. 
 
The venereal causes of genital ulcer are: 
 Syphilis 
 Chancroid  
 Herpes simplex 
 Granuloma inguinale 
 Lymphogranuloma venereum. 
 
The non venereal causes of genital ulcers are: 
 Traumatic ulcers 
 Vesiculobullous skin diseases 
 Adverse Drug Reactions like Steven Johnson Syndrome and Toxic  
Epidermal Necrolysis 
 Behcets disease 
 Erosive Lichen Planus 
 Reiters disease 
 Erythema multiforme 
 Infections due to pyogenic organisms, yeast and non specific spirochaetes, 
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 Crohn’s disease 
 Premalignant conditions like Pagets disease, Bowens disease, Erythroplasia 
of Queyrat  
 Neoplasms like Squamous Cell Carcinoma and Basal Cell Carcinoma 
 Non specific causes. 
 
HIV  
 The Human Immunodeficiency Virus is a single stranded RNA virus and 
belongs to retroviridae family. HIV seems to have been transmitted to humans 
from two non human primates infected with simian immunodeficiency virus. 
HIV-1 is the isolate transmitted from chimpanzees, and those from sooty 
mangabey monkeys are known as HIV-2. HIV-1 is the major cause of the disease 
worldwide.  
 
 The clinical spectra is similar in both infections, except for the fact that 
HIV-2 has a lower infectivity, with a longer incubation period and slower 
progression. Most of the infections have been acquired through sexual contact, 
80.8%, and about 5.1% associated with  injecting drug use and 5.5% through 
transfusion of blood and blood products and less than 1% was attributed to mother 
to child transmission of the disease. In men having sex with men, HIV infection, 
is commonly contracted through unprotected anal intercourse.  
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 Within a period of 2 to 4 weeks, seroconversion illness develops and lasts 
for about 2 to 3 weeks. It is followed by early asymptomatic HIV disease, which 
lasts for about 8 years on an average, followed by the development of late 
symptomatic HIV disease. This period indicates the advanced immunosupression 
and increase in the incidence of opportunistic infections. Finally the patient 
develops advanced disease. The infection is predominantly sexually transmitted 
and hence, genital mucosa is the major portal of entry for HIV virus.  
 
 Mucosal surfaces are rich in langerhans cells-the dendritic cells that can 
trap viral particles. Within hours after exposure of genital mucosa to the virus, the 
replicating virus is found in the regional lymph nodes. The primary viremia 
follows, leading to dissemination of the virus which leads to lymphoid tissue  
seeding  all over the body causing acute HIV infection.  
 
 During the primary viremia, very high titres of plasma viral load can be 
detected. Later, there is a development of virus specific immunity, and the virus 
becomes undetectable.  The memory CD4+ lymphocytes are preferentially 
infected by HIV and they serve as the coreceptors for the virus. Most of the 
infected CD4 cells die within a few  days of  infection.  
 
 The disease progression depends on host factors. In case of older people, 
the progression of the disease is more rapid. Seropositive intravenous drug users 
are at increased risk for the rapid progression of the disease. Coinfection with 
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hepatitis C causes a rapid progression of the disease. Severe malnutrition found in 
developing countries is associated with a rapid progression of the disease. The 
infection is divided into four stages, the Acute seroconversion illness, 
Asymptomatic stage, Early symptomatic stage, the Late symptomatic and the 
advanced stage of HIV infection (AIDS). “Acute HIV infection” or “Primary HIV 
infection” is the first stage of HIV disease.  
  
 Majority of the transmission of infection occurs across the mucosal surface 
such as anorectal, vaginal and less commonly, the oral mucosa. The receptive 
cells for the HIV are found in the lamina propria of cervico vaginal, rectal, 
foreskin, urethral and oral mucosa in studies conducted in primate models. There 
is increased expression of CCR5 chemokine coreceptor in the mucosal cells. 
During the active infection, profound depletion of CD4+ T cells occur, which is 
followed by infection of other cell types including the dendritic cells, 
macrophages and resting T cells.  
 
 Resting T cells form the major reservoir of latent HIV infection. Following 
local infection, the dendritic cells play an important role in the dissemination of 
infection. The HIV antigens infecting the peripheral tissue is brought into contact 
with T lymphocytes in the draining lymph nodes  through the dendritic cells, and 
hence plays an important role in the generation of immune response against the 
antigens.  
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 HIV enters the immature dendritic cells at the mucosal and epithelial 
surfaces and limited replication occurs in these cells, till they are carried to T cells 
in the lymph nodes. HIV bound to the unique lectin on dendritic cells known as 
DC-SIGN, remains viable for many days which provides an additional mechanism 
for the regional lymph nodal spread. This stage of infection, where there is a rapid 
rise in plasma viral load and increased number of viral particles in genital 
secretions, is significant from a public health point of  view because of the high 
infectivity.  
 
 Any breach in the genital mucosa or the presence of increased 
inflammation due to ulcerative genital disease, or urethritis or cervicitis is 
associated with an enhanced sexual transmission of the infection. After the 
establishment of HIV infection in the lymphoid tissues, the viral loads fall in the 
following weeks, due to the cellular immune response mounted against the virus.  
 
 Within days to weeks following exposure, the symptoms and signs of  
primary HIV infection may appear, lasting from a few days to 10 weeks, with less 
than 14days in a majority of individuals. Fatigue, fever and rash are the three most 
common symptoms, but nausea, vomiting, diarrhoea, night sweats, pharyngitis, 
lymphadenopathy, headache and myalgia can also occur. Diffuse maculopapular 
involving the trunk, face and the limbs with palms and soles involvement helps in 
the diagnosis. The primary HIV infection may rarely present with genital 
ulceration.  
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 Diagnosing primary HIV infection is significant in controlling the 
propogation of the epidemic. The detection of p24 antigen in the plasma or the 
serum is employed for the detection of infection during the seroconversion period. 
Identification and counseling of patients with primary HIV infection may have an 
important role in preventing the spread of infection. As the spectrum changes 
from acute syndrome to advanced disease, the CD4+ count declines, correlating 
with degree of immunosupression. When the CD4+ count is greater than 500 
cells/ µl, opportunistic infections causing systemic symptoms are less likely. 
 
 Between 200 and 500 cells/µl, sinusitis and bacterial pneumonia, 
tuberculosis are common. When the count declines to less than 200 cells/µl, many 
opportunistic infections like Candidiasis, Strongyloides stercoralis, 
Cryptosporidium parvum, Pneumocystis jiroveci pneumonia, disseminated 
Mycobacterium avium complex, Cryptococcosis, Toxoplasmosis and 
Cytomegalovirus retinitis occur. The life threatening severe infections occur when 
CD4 cell counts fall below 200/µl. Immune Reconstitution Inflammatory 
Syndrome is seen in many opportunistic infections, after initiation of Anti 
Retroviral Therapy.  
 
 It is the paradoxical worsening of the clinical status of the patient, after 
initiation of ART, inspite of improved immune function. NSAIDS, 
corticosteroids, treatment of the underlying infections and continuing ART, unless 
the response is life threatening, are the treatment principles in management of 
IRIS.  
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 More than 90 % of persons infected with HIV have cutaneous signs and 
symptoms, skin being the most common organ affected in patients with HIV. 
Dermatalogic diseases in HIV may range from inflammatory, infective or 
oncogenic disorders. They are very significant, and in most of the situations, they 
may be the diagnostic markers of HIV infection and also the opportunistic 
infections.  
 
 The skin lesions are atypical and responds poorly to conventional 
treatment. Most of the cutaneous manifestations, respond spontaneously to ART. 
The once rare disorders such as Bacillary Angiomatosis, Kaposi Sarcoma and 
eosinophilic folliculitis are brought  to attention because of the HIV epidemic 
.Lungs are the major targets of HIV  infection and pulmonary macrophages play a 
significant role in pathogenesis of  AIDS, being the discrete target cells for HIV.  
 
 The patients are at increased risk for opportunistic infections of the lung 
and neoplasms. Mycobacterium tuberculosis is the most common coinfection in 
HIV infected patients in South East Asia, especially India. Tuberculosis can occur 
at any stage, irrespective of CD4 count, though it is common when the count falls 
below 300 cells/µl.  
 
 When the count falls below 200 cells/µl, there is an increased chance of 
dissemination, with extra pulmonary involvement of central Nervous System, 
Liver, Spleen and Bone. Primary progressive lung disease is also common. 
Guidelines should be followed before the initiation of ART since, IRIS is a 
10 
 
significant issue while treating HIV/TB   coinfection. Extensive Kaposi sarcoma 
of the lung in HIV infected patients, reduces the median survival of the patients. 
Highly Active Anti Retroviral Therapy, helps in the resolution of the lesions. The 
opportunistic infections of the CNS is more common in patients not on 
antiretroviral therapy.  
 
 Apart from infections, other manifestations like peripheral neuropathy, 
neoplasms, dementia can also occur in the HIV infected patients. Diarrhoea is the 
most common manifestation of HIV infection, the opportunistic infections being 
the most common cause. The clinical presentation differ according to the site of 
involvement of Gastrointestinal tract. GIT is the common site of HIV associated 
Non Hodgkins Lymphoma. HIV associated lipodystrophy which includes 
hyperglycemia, insulin resistance and hyperlipidemia increases the risk of 
cardiovascular disease.  
 
 The incidence of NHL is 60 to 200 times high in the HIV infected people 
when compared to the uninfected. HAART has led to the decrease in the 
incidence of Kaposi sarcoma and AIDS related lymphoma.  Rheumatic 
manifestations ranging from non specific inflammation, non inflammatory pain 
syndromes and autoimmune syndromes like vasculitis, sjogrens syndrome, are 
more common in the late stage of infection. These disorders are significant in the 
view of treatment , since  the immunosuppressive agents used in the treatment of 
rheumatological conditions, may rapidly cause full blown AIDS.  
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 Ocular diseases in HIV can practically involve any structure of the eye. In 
case of involvement of posterior segment, early diagnosis and treatment is 
essential, since it can lead to irreversible blindness.  After the introduction of 
HAART, the incidence of ocular complications has decreased.9 
 
 
HIV infection and genital ulcer: 
 The epidemic of HIV in the past few years, has caused a significant impact 
on the transmission, course and treatment of genital ulcer disease, and GUD also 
has an impact on the transmission and the course of HIV infection.2 Regardless of 
the cause of the ulcer, the mere presence of ulcers are associated with an increase 
in the risk of transmitting or acquiring HIV.10 HIV and other STDs have a 
reciprocal relationship which is called as epidemiological synergy, each altering 
the transmission and manifestations of other STDs.11 Genital ulcers could facilitate 
the transmission of HIV1 by increasing the infectiousness of the index case or the 
susceptibility of the partner or both.12,13  
 
 Through different biological mechanisms, the genital ulcers promote the 
transmission of HIV by increasing the infectiousness and HIVsusceptibility.14 
Increased number of HIV infected white blood cells in genital ulcers contribute to 
the infectivity cofactor effect.15 A number of studies from different parts of India 
have shown an  increasing prevalence of HIV in patients who attend STD clinics 
with genital ulcer disease than in the non ulcerative STD patients.16-19  
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 Genital Ulcer Disease has a great impact on the spread as well as the 
course of HIV. Ulcers cause impairment of the normal epithelial barrier, increased 
HIV shedding from the genital tract, recruiting and activating the cells susceptible 
to HIV at the lesional site, thereby promoting the replication of HIV.20  
 
 HIV also influences the course of other sexually transmitted diseases in 
reactivating latent infections, modifying the original course of the disease, altering 
clinical picture, challenges in treatment with failure in conventionally followed 
treatment regimes, altering serological test results and histopatholological picture, 
thereby posing diagnostic difficulties.2 In a case study of four cases of genital 
ulcers in Nigeria, in HIV coinfection the ulcers were long standing, aggressive in 
nature, recurrent and associated with systemic symptoms.21 
 
Herpes genitalis: 
 Herpes genitalis is caused by Herpes virus hominis, a DNA virus. It is the 
most common sexually transmitted pathogen causing genital ulcer worldwide and 
is the most frequent opportunistic infection in HIV infected adults. The virus is of 
two types-type1 and type2.22 The genital lesions are predominantly caused by type 
2 virus23 though type-1 may be isolated from one third of the cases. Herpes 
genitalis is a persistent infection in the sensory ganglion, running a chronic 
course, with varying degrees of epithelial expression characterized by 
asymptomatic or symptomatic recurrences. After a primary infection, virus 
persists in the sensory nerves which is termed as the latency, during which the 
host immune system fails to recognize the virus.  
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 The virus is reactivated following various triggers, and travel to the skin or 
the mucous membrane, and the replication causes the recurrent disease. The 
shedding of virus occurs even in the absence of lesions clinically-asymptomatic 
shedding, though the number of viral particles that are shed are very less 
compared to those from an active lesion.22 Asymptomatic shedding of virus is 
responsible for about 70% of transmission.24 Infection spreads through direct 
contact with the infected secretions.  
 
 The average incubation period is about 5 to 14 days. The first episode of 
the infection is more severe in nature and associated with systemic symptoms like 
headache, fever, malaise and myalgia. Painful ulcers are common and lasts for 
upto 2 weeks. Grouped vesicles are the initial lesions which rapidly become 
pustular and then ulcerate. Ulcers present as large coalescing areas with 
polycyclic margins. Localized lymphadenopathy and urethral discharge are 
common.  
 
 New lesions occur in the first 10 days and it takes about three weeks for the 
complete reepithelization to occur. Shedding of virus usually occurs in the first 
two weeks. Scarring is not common.22 Recurrent episodes of genital herpes are 
milder in nature with a shorter duration of about 5-7 days. The viral shedding 
period is between 3 to 4 days and complete healing occurs by 7 to 10 days.  
 
 Recurrences are more common and earlier in HSV-2 infections. The 
clinical presentation in recurrences is not typical with grouped vesicles as in first 
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episode. The transmission of HIV is facilitated by the persistent genital ulcers of 
HSV.22 The presence of HSV infection increases the transmission and replication 
of HIV. Herpes simplex virus infections are more frequent and more severe in 
HIV patients with immunosupression.25-27 A synergistic relationship exists between 
HSV and HIV thereby leading to increased replication of the viruses and 
increased potentiation of transmission of HIV.28  
 
 Antiretroviral therapy decreases the severity and frequency of symptomatic 
genital herpes, but subclinical shedding still continues to occur.29 Asymptomatic 
HSV shedding and prolonged and continuous viral shedding is more common in 
HIV seropositive than seronegative individuals. Perianal HSV shedding is also 
more common in HIV seropositive individuals. Coexistent HIV infection leads to 
more frequent and prolonged episodes of genital herpes with decreased response 
to acyclovir.  
 
 Atypical presentations of genital herpes like extremely painful ulcers, 
hyperkeratotic verrucous lesions, deep progressive ulceration, hemorrhagic and 
ecthyma like lesions, pseudotumor of tongue, pneumonitis, hepatitis, oesophagitis 
and disseminated infections which are life threatening  are common in coinfection 
with HIV.22,23 In HIV positive patients, recurrences are more persistent, as against 
self limiting lesions in HIV uninfected patients.22 The diagnosis in typical cases is 
usually made clinically.  
 
15 
 
 The laboratory investigations available for the diagnosis of herpes simplex 
virus infection are Tzanck smear, histopathology, culture, serology, and 
polymerase chain reaction. The Tzanck smear is stained with giemsa and 
multinucleate giant cells are seen. The test is negative in later stages and has a low 
sensitivity. The test does not differentiate between HSV-1 and HSV-2. 
Histopathology is rarely performed. Culture is the definitive means of diagnosis of 
herpes simplex virus and usually positive in the primary infection and negative in 
about 50% of recurrences.  
 
 Negative results are more common in dry erosions or crusted lesions.22 
Enzyme Linked Immunosorbent Assay, Western Blot, Complement Fixation Test 
are employed for detection. The current generation of tests have a high sensitivity 
and specificity.30,31 Various studies have shown Polymerase Chain Reaction, to be 
superior to culture in detection of virus from mucocutaneous swabs.32-34 Antiviral 
drugs used in the treatment of HSV infections are Acyclovir, Valacyclovir and 
Famciclovir. In cases of acyclovir resistance, foscarnet, trifluridine and cidofovir 
are used. Vaccines are used for the prevention of acquisition of infection.22 
 
Syphilis : 
 Syphilis is a chronic sexually transmitted bacterial disease caused by 
thespirochaete, Treponema pallidum, subspecies pallidum, a thin delicate, motile, 
tightly coiled organism with tapering ends, belonging to the order, Spirochetales 
and the family, Spirochetaceae. Humans are the only natural host and the reservoir 
of infection. The disease is systemic from outset, can   involve any structure of the 
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body, can be completely asymptomatic or can cause florid manifestations, and is a 
great imitator of many other diseases.  
 
 The disease has early or the infectious stage which includes primary, 
secondary and early latent stages and the late or non infectious stage which 
includes late latent and tertiary stages.  The disease spreads through sexual contact 
from an infected person who is in the early stage of the disease or transmitted 
from mother to fetus during primary, secondary or early latent stage. The adverse 
outcomes of transmission to fetus like still birth and congenital syphilis and the 
transmission of HIV through the ulcerative and inflammatory lesions of syphilis 
in primary and secondary stages is of significant public health importance.35 
 
 Treponema pallidum penetrates through minor breaks in the skin or the 
mucosa. Studies suggest that treponema pallidum stimulates the fibroblasts to 
synthesis increased levels of interstitial collagenase, which might help the 
organism to penetrate the cell.36 The organism slowly multiplies  at the site of 
inoculation and when the number of organisms reach a threshold level, the 
primary lesion develops. The ulcer (chancre) is the primary syphilitic lesion and 
usually appears within 9 to 90 days ,at the site of inoculation, usually on the 
genitalia. The lesion usually starts as a dusky red and  a painless macule of about 
0.5-1 cm in size which becomes a papule and the size increases and ulcerates.  
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 The ulcer is painless and non tender, with edges being well defined and 
regular, the floor being clean with dull and red granulation tissue with the 
characteristic induration at the base and highly contagious serous exudate present 
on manipulation of the ulcer. Chancre is single in a majority of the 
patients..Regional lymph nodes enlargement is seen within 7-10 days, initially 
unilateral, later becoming bilateral.37  
 
 The primary chancre heals in an average period of about twelve days. In 
most patients, the primary chancre heals before the lesions of secondary syphilis. 
The lesions of secondary syphilis start appearing in approximately 8 weeks from 
the time of contact, with a range from 1 to 12 months.38 After the resolution of the 
secondary stage, the person remains asymptomatic and the stage is termed as the 
latent stage, during which, positive serology is the only evidence of infection. The 
latent stage is further divided into early latent, which is infectious and the non 
infectious late latent stage.39,40  
 
 The latent stage is of a long period, which might last for many years, or 
may result in spontaneous cure. The tertiary stage develops eventually, 
manifesting as cardiovascular or the neurosyphilis or the benign gummatous 
lesions of the skin and other organs. In this stage of the disease, the treponemes 
are sparse and the immunological mechanisms play an important role in the 
pathogenesis.  
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 The ulcerative lesions of primary and secondary syphilis facilitates the 
transmission of HIV.35 Primary chancre causes a breach in the epithelium, 
providing easy access for HIV to the CD4 lymphocytes, which contribute the 
major proportion of cells infiltrating the lesional site. In HIV and Syphilis 
coinfection, CD4 counts fall rapidly and the viral load increases rapidly.41,42  
 
 In a community based study, a 10 times higher incidence of syphilis in HIV 
seropositive Men having Sex with Men(MSM) compared to HIV negative MSM 
was found, and this was attributed to behavioral factors and unprotected anal 
intercourse.43 In patients with advanced HIV, syphilis presents with unusual 
features clinically. Persistant chancre, painful chancre, multiple primary chancres, 
giant primary chancre are common in HIV positive individuals.44-47  
 
 The persistence of primary chancre and the rapid progression to secondary 
syphilis can occur and it also increases the transmission of HIV.48 Malignant 
secondary syphilis known as Lues maligna, an explosiveand widespread 
secondary syphilis, starting with a prodrome of fever, myalgia and headache, 
succeeded by a papulopustular eruption, that rapidly breaks down to necrotic 
ulcers with sharp margins with hemorrhagic crusts, is found to be 60 times more 
common in HIV infected people when compared to the normal population.49  More 
rapid progression to neurosyphilis can occur in coinfection50 and asymptomatic 
neurosyphilis is more common.51  
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 The clinical and serological response to treatment of syphilis with 
penicillin is unaltered in HIV and syphilis coinfected patients.52 The exudates 
from the mucocutaneous lesions of early congenital and early acquired syphilis is 
subjected to dark field microscopy, by which the diagnosis of primary syphilis can 
be made weeks before the serological tests become reactive. Serology plays a 
significant role in the diagnosis of syphilis, since treponema pallidum cannot be 
sustained in cultures. Multiplex PCR assays, which can simultaneously detect 
treponema pallidum, haemophilus ducreyi and herpes simplex virus 1 and 2 in 
genital ulcer disease have been developed.53 
 
Chancroid: 
 Chancroid is relatively a common cause of genital ulcer in developing 
countries like India and Africa.54 Soft sore, soft chancre and ulcus molle are the 
other names denoting chancroid. The disease was first described as a separate 
entity by Ricorde. Chancroid is an endemic disease in many developing countries 
like Kenya , Zimbabwe and Zambia.55  
 
 Chancroid is caused by a gram negative facultative anaerobic bacillus 
called Haemophilus ducreyi. H.ducreyi is strictly a human pathogen, which can 
naturally infect the skin, mucosa and regional lymph nodes with increased 
preference for the mucosal epithelium.56 Low hygienic standards and 
uncircumcised status are associated with the increased prevalence of the disease.57  
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 The disease is more common in males when compared to females and the 
ratio of male to female incidence ranges from 3:1 to 53:1.58 The variation in 
incidence, being higher in males compared to females is attributed to facts like 
asymptomatic ulcers of cervix or vagina in females with spontaneous healing, 
lymphadenitis and bubo formation being less frequent in females, and better 
visibility of the lesions on male genitalia.56  
 
 Commercial sex workers and people belonging to lower socioeconomic 
status are at increased risk of acquiring the disease. The disease is mainly 
transmitted through heterosexual contact, usually the infection being acquired 
from sex workers.59 The estimated risk of transmission of chancroid from an 
infected male to a female who is free of disease during a single sexual act is about 
0.35 as against 0.30 in case of transmission from an infected female to an 
uninfected male during a single sexual act. The total duration of infectivity was 
estimated to be about 45 days.60 The minor trauma or the abrasion that occurs 
during the sexual intercourse is the route through which the organism is 
inoculated into the tissues.61 The average incubation period ranges from 1 to 14 
days.62  
 
 The lesion starts as a small inflamed papule with a surrounding erythema 
on the genitalia, rapidly progressing to a pustule, quickly breaking down to form 
multiple painful sharply circumscribed foul smelling ulcers with ragged 
undermined edges. A yellowish, necrotic and purulent exudate covers the floor of 
the ulcer. On removal of the exudate, a richly vascular granulation tissue is found, 
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that on scraping or on gentle manipulation, bleeds. Multiple ulcers are seen in 
about 50% of the cases due to autoinoculation.56  
 
 The inner surface of the prepuce, frenulum and the coronal sulcus are the 
common sites infected by the bacilli. Within a span of 1 to 2 weeks, painful 
inguinal lymphadenitis develops in about 30 to 60 % of the patients. The nodes 
are unilateral in most patients, become enlarged and matted and suppurates 
forming an abscess called a bubo, when left untreated ruptures to form a sinus.  
 
 The opening of the sinus, breaks down to form a chancroidal ulcer, which 
can sometimes enlarge to form a giant ulcer.63 In the presence of chancroidal 
ulcer, the transmission of HIV is increased.64,65,66 More frequent HIV 
seroconversion is seen in heterosexual men suffering from genital ulcer disease 
than in men without genital ulcer. Haemophilus ducreyi infection evokes a cell 
mediated immune response and attracts the HIV susceptible cells to the site of 
ulcer.  
 
 The macrophages present at the site of chancroid, have an increased 
expression of CCR5 and CXCR4, the two important chemokine receptors which 
are essential for the entry of HIV. The disrupted epithelial barrier along with the 
up regulated receptors provide a conducive environment for the acquisition of 
HIV infection.67 Ulcers bleed during intercourse potentially increasing the viral 
shedding and HIV infectiousness.68  
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 In case of coinfection with HIV, the number of ulcers are more in number 
and take a longer time to heal. Extensive necrotizing ulcers with multilocular 
buboes are common in HIV coinfection. Atypical ulcers of larger size and number 
with extragenital location are also common.68,69 Decreased responsiveness to the 
standard single dose treatment regimens  are common in chancroid and HIV 
coinfection.70,71,72 
 
Lymphogranuloma venereum: 
 Lymphogranuloma venereum is a sexually transmitted disease caused by 
Chlamydia trachomatis biovars L -1,2,3. Sexual transmission is the most common 
mode of transmission of the disease, but non venereal transmission from ruptured 
buboes to health care personnel and infection through infected  birth canal can 
occur.73 LGV is more common in men than women, the asymptomatic nature of 
the lesions in females being a reason for the under diagnosed state in them.74 
 
 Commercial sex workers have a significant role in the transmission of the 
disease. The maximal incidence is in the second and third decade of life, which 
corresponds to the peak age of sexual activity. The disease is more common 
among men having sex with men, people belonging to lower socioeconomic class, 
and sexually promiscuous individuals. LGV is a disease of long course and of 
destructive nature.  
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 The organism is lymphotropic and initiates the disease process by 
thrombolymphangitis and perilymphangitis. Inoculation occurs through the 
abrasion in the skin or the mucous membrane and then the organism gets 
concentrated in the draining lymph nodes, producing lymphangitis and 
lymphadenitis.  
 
 The proliferation of endothelial cells occur in the lymphatics and the lymph 
channels in the involved lymph nodes. Enlargement and necrosis of the regional 
lymph nodes occur. Neutrophils are attracted to the site and it leads to the 
formation of the quadrangular or the triangular stellate abscess, that is surrounded 
by macrophages, epitheloid cells and the giant cells. The abscesses coalesce to 
form a multilocular abscess, which undergoes spontaneous rupture, forming 
fistulae and sinus tracts.  
 
 The inflammation subsides and followed by fibrosis which leads to 
obstruction of lymphatic channels in the submucous and subcutaneous tissue 
causing lymphoedema, brawny induration and elephentiasis. The overlying skin 
and the mucous membrane undergoes ischemic necrosis and ulceration due to 
compromise in the regional blood supply that occurs secondary to fibrosis. The 
systemic infection can occur due to hematogenous spread of the organism. The 
tissue damage that occurs in LGV is mainly due to cell mediated hypersensitivity 
response mounted against chlamydial antigens.75  
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 Clinically the presentation of the disease varies according to the patient’s 
sex, mode of  sexual contact, and the clinical stage of the disease. The clinical 
features are grouped as a spectrum consisting of primary stage, secondary stage or 
the inguinal syndrome and the tertiary stage or the genito-anorectal syndrome. 
Apart from these there can be urethro-genito-perineal syndrome and significant 
ocular and cutaneous manifestations.76,77  
 
 The incubation period averages from 7 to 12 days for primary stage but can 
be as long as 6 months. The primary lesion usually occurs over the coronal sulcus, 
starts as an asymptomatic papule, becomes a pustule and transforms into a 
herpetiform ulcer.74  
 
 Bloody discharge, diarrhoea and cramps occur in MSM due to primary 
rectal inoculation.78  Secondary stage starts within 2 to 6 weeks after primary 
lesion, but may be prolonged as long as 4 to 6 months. This stage is characterized 
by severe proctitis, bubo formation and inguinal multilocular abscess. In MSM, 
LGV proctitis is common, characterized by perianal ulcers, anal cramps, tenesmus 
and bloody discharge.  
 
 The tertiary stage develops in about 25 % of the untreated patients, more 
commonly in women. The persistent infection elicits a chronic inflammatory 
response, and causes proctocolitis, “lymphorroids”, which is the hyperplasia of 
the intestinal and perirectal lymphatics, strictures, rectal stenosis and fistulae.79  
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 Ocular manifestations can occur at any stage of the disease due to 
autoinoculation. The disease can present as iritis, episcleritis, iridocycitis, 
conjunctivitis and corneal ulcers. Cutaneous manifestations are due to 
hypersensitivity reaction to LGV antigens, and can present as diffusely spread 
papules, pustules, nodular lesions, urticaria, erythema nodosum, erythema 
annulare centrifugum or erythem multiforme.80  
 
 Lymphogranuloma venereum, being an ulcerative disease, there is an 
increased transmission of HIV as well as hepatitis C. Most of them were 
associated with the high risk sexual practices causing anal trauma.81 In a 
retrospective analysis of 27 LGV patients in a hospital in Paris, in 6 patients, a 
concomitant HIV infection was found.82   
 
 The LGV epidemic among men having sex with men, around 80% were 
coinfected with HIV76,77,83  and hepatitis C coinfection was found in upto 18%.76,84  
LGV can be diagnosed by commercially available Nucleic Acid Amplification 
Test and Polymerase Chain Reaction. Cell culture using cell lines such as baby 
hamster kidney cells, HeLa 229, McCoy cells are used. Cytology by staining with 
special stains such as Giemsa, Warthin-starry, Grocott methenamine silver, 
phosphotungstic acid hematoxylin are also used for diagnosis.53 
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Hepatitis C 81,85,86,87 
 Hepatitis C virus is an enveloped virus that belongs to the Flaviviridae 
family. The HCV genome is a single stranded positive sense RNA, of about 9.4 
kb length. Based on the nucleotide sequence diverge, 6 genotypes, HCV 1 to HCV 
6 are observed and subtypes are denoted as a,b, etc., This genetic heterogeneity 
occurs because the viral RNA polymerase which helps in the replication, lacks a 
proof reading exonuclease, and hence error prone.  
 
 The virus is capable of causing a persistent infection in a majority of the 
patients and hence considered notorious. Such patients are more likely to develop 
cirrhosis and hepatocellular cancer. The prevalence of chronic hepatitis C 
worldwide is 0.5 to 2 %, which accounts for 150 million carriers in the world. The 
distribution of genotypes are different in different parts of the world.  
 
 The genotypes HCV 1 and HCV 2 are common in western Europe, West 
Africa, Australia, Japan and North America. In India HCV 3 is common. HCV 4 
is common in Egypt and Central Africa and HCV 5 being common in South 
Africa and HCV 6 in South East Asia. Prevalence is more common in men, with a 
progressively increasing incidence with increasing age.  
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 Thalassemia patients, patients with haemophilia, recipients of 
haemodialysis, injecting drug users, persons who have got tattoos, prisoners, 
alcoholics have increased prevalence of anti-HCV. In Europe and Japan, the 
prevalence of chronic HCV infection is very high in patients with chronic 
hepatitis, cirrhosis and hepatocellular carcinoma. HCV transmission occurs more 
commonly through blood and blood products.  
 
 In the past, HCV accounted for 85% of post transfusion hepatitis that has 
now decreased to 4 %, due to exclusion of paid donors and the mandatory 
screening of blood for HCV. HCV also occurs through other routes such as 
injecting drugs usage, where the sharing of needles and syringes is identified as 
the risk factor in the transmission of the disease.  About 50% to 80% of people 
involved in injecting drug use, turn HCV positive in a period of twelve months of 
starting drug use and by 8 years, all are anti HCV positive.  
 
 The healthcare workers are at risk of seroprevalence, with the greatest risk 
among dental surgeons.  The health care workers who get exposed to HCV 
positive blood by accidental needle stick injuries have a serocoversion rate of 
about 1.8% on an average. In the past, HCV infection was more among patients 
with renal failure, because of shared hemodialysis machines. Nowadays, patients 
are routinely screened for HCV infection, and if found positive, hemodialysis is 
carried out in separate machines designated for infected patients.  
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 About 10% of uninfected hemodialysis patients, are at risk of acquiring 
new HCV infection, following transplantation, particularly those receiving more 
than one kidney or more than five units of blood. Of about 50 % of the organ 
recipient patients, from donors who were positive for antibody to HCV developed 
hepatitis after organ transplantation. Hence antibody positivity to HCV is now an 
exclusion criterion for organ donation.  
 
 The transmission of HCV can also occur through non percutaneous mode 
which includes, transmission that occurs between sexual partners and the 
transmission from mother to the offspring. The available evidences suggest that 
the non percutaneous transmission routes, including sexual route, is rare and 
inefficient when compared to transmission of hepatitis B virus. The transmission 
of HCV through sexual route is not well defined.  
 
 In prospective studies conducted studying the rate of transmission of HCV 
in sexual partners of infected patients, the transmission rate seemed to be less than 
1% per year, whereas there was much more transmission of HIV and HBV, which 
indicates that sexual transmission  is an important route of HIV and HBV 
acquisition and not of HCV. The spread of HCV through heterosexual contact is 
reported from Thailand, Argentina and Egypt. HCV infection through homosexual 
contact has been reported from European countries.  
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 The risk of acquiring HCV infection in the spouse of an infected patient, in 
a long term monogamous relationship is about 4 % on an average.  The pattern of 
sexual relationship also plays a significant role in determining the transmission of 
HCV.  
 
 The anti-HCV prevalence was about 1 to 10 % in the sexual partners of 
index patients, without high risk behaviors like promiscuity or injecting drug use, 
whereas it was around 11 to 27 % in partners of patients with high risk behavior. 
Studies also suggest that the sexual transmission of HCV is more efficient from 
male to female when compared to female to male. Studies show that, presence of 
genital ulcer disease seems to be associated with increased sexual transmission of 
HCV.  
 
 Men who are involved in homosexual practice have an increased rate of 
anti-HCV positivity when compared to those who have a monogamous 
heterosexual contact. Multiple sexual exposure with multiple partners and 
injecting drug use adds to the risk of increased acquisition. A study conducted in 
homosexual men, the risk factors for sexual transmission of HCV were anal 
receptive intercourse, having a sexual partner with injecting drug use, history of 
genital herpes, and seropositivity for HIV.  
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 There is a steady increase in acute HCV infection in HIV seropositive 
homosexual men, during the last ten years, in various parts of the world , and this 
is attributed to traumatic anal sex, presence of other  genital ulcer disease like 
syphilis, herpes and  lymphogranuloma venereum, and recreational drug usage.  
 
 The sexual partners of injecting drug users, heterosexuals with multiple 
partners, prostitutes and their clients are all at an increased risk of acquiring the 
disease. The coinfection of HIV and HCV increases the sexual transmission of 
HCV suggesting that HIV may act as a cofactor in HCV transmission. The 
transmission rate of HCV is 5 times increased when HIV is also transmitted. As a 
result of immunosuppression in case of HIV coinfection, there is an enhanced 
viremia, and hence the sexual transmission of HCV is more profound, indicating 
that viral load is also a very important factor in deciding the rate of transmission.  
 
 The significant immunological changes in HIV coinfection and presence of 
mucosal defects facilitate the acquisition of HCV. Since the cell mediated 
immunity is defective in HIV, HCV clearance is reduced and increased loads of 
HCV is found in serum and semen. In HCV/HIV coinfection, the course of liver 
disease is more rapid and there is twice increased risk of liver cirrhosis when 
compared to patients with HCV infection alone.15  
 
 In a study conducted in slums of urban Chennai, regarding the sexual 
exposure and HCV infection, HCV infected patients gave a history of having 
suffered from genital ulcer in the past, indicating the significance of presence of 
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ulcerations in the enhanced disease transmission. The rate of perinatal 
transmission of HCV is about 2 to 8 % which is very low when compared to 
perinatal  transmission of hepatitis B. In case of HIV/HCV coinfection , the 
transmission rate is increased to 36 to 44 %. The greater risk of HCV acquisition 
in the fetus is associated with the higher titres in the mother. Acute HCV infection 
presents with asymptomatic elevation in the levels of liver enzymes. 
Constitutional symptoms like anorexia, loss of weight, pain abdomen, myalgia 
and mild jaundice can occur. All the symptoms usually resolve in a period of 
about three months.  
 
 The occurrence of fulminant hepatic failure is very uncommon in HCV 
infection. As early as 1 week after exposure, the HCV-RNA, can be detected by 
PCR in acute hepatitis C infection. The antibodies against HCV can be detected 
about 4 to 8 weeks after exposure, though it may take about more than three 
months to appear. In about 60 to 70%, the risk of chronic infection is present. In 
chronic HCV infection, fatigue is the commonest symptom, which is followed by 
right sided upper abdominal pain.  
 
 Hepatomegaly and splenomegaly is present in patients who have developed 
liver cirrhosis. Enzyme elevation is widely variable in the course of the disease. 
Histologically chronic hepatitis C is associated with characteristically, more 
lobular and degenerative changes, macrovesicular steatosis, eosinophilic granules, 
sinusoidal cell activation and bile ductal lesions.  Chronic hepatitis C has a slow 
progression, requiring 1 to 2 decades post infection, for minimal deterioration to 
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occur.  But the survival rate is poor in patients who have developed cirrhosis, 
which is only 50% survival in more than 5 years. The cofactors implicated in the 
progression of HCV includes alcohol intake, male sex, age above 45 years, 
ethnicity, the immune status of the host and the presence of HIV coinfection.  
 
 The extrahepatic manifestations of chronic HCV includes presence of 
autoantibodies such as antinuclear, anti thyroid and anti smooth  muscle 
antibodies, essential mixed cryoglobulinemia, cutaneous leucocytoclastic 
vasculitis, cryoglobulinemic renal disease, arthralgia, porphyria cutanea tarda, 
lichen planus, polyarteritis nodosa, urticaria, prurigo, erythema nodosum and 
erythema multiforme, non hodgkins B cell lymphoma and autoimmune 
thrombocytopenia purpura.  
 
 Detection of antibodies against HCV antigen, serum HCV RNA, and HCV 
genotyping are employed in the diagnosis of HCV infection. Pegylated interferon 
alpha is used in the treatment of acute hepatitis C infection and in chronic 
infection, weekly pegylated interferon alpha along with daily ribavirin is used in 
treatment. 
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Hepatitis B 
 Hepatitis B is caused by a DNA virus, the Hepatitis B Virus, a prototype of 
hepatotropic DNA viruses (hepadnaviruses). The infectious virion is a spherical 
and double shelled structure, of 42 nanometer diameter size, known as the Dane 
particle. The outer shell is the surface antigen-HBsAg, surrounding the inner core 
protein-the core antigen-HBcAg containing nucleocapsid. The HBV genome is 
relatively stable. Seven genotypes are described-A to G, based on the divergence 
in nucleotide sequence of 8 % or more.  
 
 The genotypes have a different geographic distribution. Genotype D is 
common in India. The pathogenesis and the treatment response to antiviral agents 
vary between the different genotypes. In different parts of the world , the carrier 
rate ranges from 0.1% to 20%. In India it is between  1.1% to 12.2% in the 
general population.  
 
 The transmission of hepatitis B virus is mainly through three ways- vertical 
transmission, sexual route and parenteral transmission. A source, an effective 
mode of spread and a susceptible host are all essential for the transmission to 
occur. The blood and blood products of chronic carriers of HBV is the source of 
HBV infection. A single and a minute exposure is  sufficient to transmit the 
disease, since the hepatitis B virus is present in very large amounts in the blood.  
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 The viral load in the blood correlates with the infectivity of the sample. 
The presence of HBeAg is significant, because when present along with HBsAg, 
the viral load is very high and hence a minor needle stick injury is sufficient for 
disease transmission. Transmission can also occur through HBsAg negative blood 
transfusion during the window period of HBV infection.  
 
 The concentration of HBsAg in urine, feces, breast milk, sweat, tears, 
vaginal secretions and cerebrospinal fluid is very low and hence the secretions 
have not proven to be infectious. Infection has been reported to be transmitted 
through semen, but the amount of virus in semen is around 100 to 1000 times less 
than that in the blood.  
 
 Therefore the major risks in parenteral transfusion are after blood 
transfusion, untreated plasma products exposure, needle stick injuries, use of 
unsterilized instruments, tattooing, acupuncture and dentistry. Injecting drug use 
is also a proven source of disease transmission. In the past when blood and blood 
products were used without screening, hemophiliacs, who were frequently 
transfused with factor VIII concentrates, had a higher incidence of hepatitis B 
infection.  
 
 In areas with a low to intermediate level of prevalence of infection, sexual 
route is the most important way of HBV transmission. The manner of sexual 
transmission of infection has not been clearly defined.  
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 HBV antigen can be detected in semen, and the breach in the skin or the 
mucous membrane increases the rate of transmission. Sexual activity has been 
incriminated as the source of transmission in anal intercourse, particularly in the 
receptive partners. In case of heterosexuals, the spread occurs through minute 
lacerations in the penis or the vagina and when HBV is present in the semen or the 
vaginal secretions.  
 
 The risk factors for increased transmission in heterosexuals include number 
of sexual partners, duration of sexual activity, reactive serology for syphilis, and a 
history of other sexually transmitted infections. Risk factors for viral acquisition 
in homosexual population includes, having multiple sexual partners, receptive 
anal intercourse, and the duration of sexual activity. Commercial sex workers and 
the clients, and partners of injecting drug users are at increased risk of acquiring 
HBV infection.  
 
 Active viral replication with high HBV-DNA/HBeAg positivity facilitates 
the sexual transmission of the infection. Condom usage appears to decrease the 
risk of sexual transmission. Among the sexual contacts of men who suffered from 
hemophilia or injecting drug users, the higher rates of antibodies were found 
against hepatitis B than HIV or HCV indicating that HBV may be more rapidly 
spread by sexual contact than HIV and HCV.85  
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 In areas of high prevalence of HBV, perinatal transmission is a very 
significant mode of transmission. High plasma viral load, especially when it is 
more than 2×10000 IU/ml is associated with an increased rate of transmission. 
The high viral load and HBeAg positivity in the mother is more likely to 
accelerate the transmission of the disease. The babies infected are asymptomatic 
and they have about 90% chances of developing a chronic infection which is more 
in comparison to adults where there is only 5 to 10 % chance of developing a 
chronic infection. 
 
 The infant acquires the infection through inoculation of maternal blood or 
liquor that occurs during the passage through the vaginal canal, rather than the 
intrauterine transmission.85 After the exposure to the virus occurs, the virus is 
transmitted through blood to the liver. The virus gets attached to the hepatocyte. 
The uptake of HBV into hepatocyte is mediated by sialoglycoprotein receptors on 
the hepatocyte, possibly through endocytosis.  
 
 When the virus enters the hepatocyte, the nucleocapsid is transferred to the 
nucleus, followed by translation and reverse transcription and finally assembly of 
mature virions. During the process of the viral replication, some of the HBV-DNA 
gets integrated into the host chromosomal DNA. This integrated HBV-DNA is 
implicated in the development of hepatocellular carcinoma after many years.  
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 In acute hepatitis, maximal HBV replication occurs before the maximal 
cellular injury, indicating that the disease might represent the immunologically 
mediated lysis of the infected hepatocytes. Even at the maximal concentrations of 
virus in the serum and liver, liver disease is very minimal, with little or no 
evidence of hepatocyte necrosis on biopsy, which suggests that the virus is not 
cytopathic.  
 
 An efficient HLA class 1 and class 2 restricted T cell response to viral 
proteins clears virus in acute hepatitis B .  In chronic infection, there is a weak 
HLA class 2 restricted T cell response, which is insufficient for clearing the 
replicating virus. Patients with immunosupression , for example those on 
hemodialysis, post renal transplant recipients, patients suffering from leukemia or 
leprosy and patients with HIV coinfection are more prone for chronic infection. 
Clinically, the manifestations of hepatitis B infection depend on the factors like 
age at which the infection occurs, the immunological status of the host, the rate of 
replication of the Hepatitis B Virus.  
 
 A spectrum of manifestations are seen ranging from subclinical hepatitis to 
anicteric hepatitis followed by icteric hepatitis proceeding to fulminant hepatic 
failure in acute phase of the infection. The incubation period of acute hepatitis B 
ranges from 40 to 140 days. The preicteric or the prodromal phase consists of 
symptoms like anorexia, nausea, vomiting, fatigue, fever of low grade, malaise 
and myalgia. Few patients have a serum sickness like syndrome and a generalized 
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maculopapular rash or urticaria. This phase lasts for about 3 to 7 days, followed 
by icteric phase, where jaundice occurs and the constitutional symptoms decrease. 
This phase may last upto twelve weeks, followed by a convalescent phase, where 
there is a resolution of  jaundice and disappearance of other symptoms and 
improvement in appetite. The last symptom to disappear is fatigue.  
 
 The clinical examination in acute hepatitis shows icterus, fever of low 
grade and tender and soft hepatic  enlargement. There is a 10 to 50 fold elevation 
of levels of alanine aminotransferase and aspartate aminotransferase. Serum 
bilirubin levels and  prothrombin time are the markers of prognosis. The 
persistently elevated levels of  ALT for a period of more than 6 months duration 
are suggestive of chronic liver injury.  
 
 Liver biopsy reveals disarray of lobular architecture, hepatocytes showing 
acidophilic degeneration, focal lobular necrosis, lymphocytic and macrophage 
infilteration of the parenchyma, kupffer cell hypertrophy and hyperplasia, bile 
ductules disruption and cholestasis. HBsAg is the first serological marker that is 
detected in the serum, which appears during the incubation period and lasts upto 5 
months  or longer.  
 
 The first antibody to appear is IgM antiHBc and persists upto 12 months. 
IgG antiHBc also appears early and persists for life.85 In the chronic phase of the 
infection, the spectrum ranges from a carrier state which is asymptomatic to 
chronic hepatitis, followed by cirrhosis, ultimately proceeding to hepatocellular 
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carcinoma. As the age at which the infection is acquired, increases,the probability 
of developing chronicity, decreases. Chronic infection is more common in men. In 
a majority of patients, the onset of infection is mild or totally asymptomatic or 
may have nonspecific symptoms like intermittent fatigue which worsens with 
exertion or the patients may have anorexia, nausea, jaundice, low grade fever and 
weight loss. When the patient develops cirrhosis, there is weakness, weight loss, 
wasting, edema, abdominal swelling, jaundice, encephalopathy and variceal 
bleeding.  
 
 Few may present with extrahepatic manifestations. Rarely few patients 
may present with hepatocellular carcinoma. Clinically edema, abdominal 
swelling, spider angiomas, splenomegaly, distended veins over abdomen and 
ascites is seen in patients with cirrhosis. Esophageal varices may be seen on 
endoscopy. There may a 5 to 8 fold rise in aminotransferase levels with ALT 
higher than AST and AST:ALT ratio lesser than1.  
 
 With the increasing liver dysfunction, prothrombin time and serum 
bilirubin increases and serum albumin decreases all pointing towards a poor 
prognosis. Few patients may develop a complicated clinical course characterized 
by fulminant hepatitis, post hepatitis syndrome, relapses and chronic hepatitis. 
Hepatocellular carcinoma occurs after decades of chronic HBV infection. The 
patients present with constitutional symptoms, abdominal mass and a 
decompensated liver disease.  
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 In acute hepatitis B, lamivudine or entacavir are indicated in cases of 
impending acute liver failure. In case of chronic hepatitis B, pegylated interferon 
alpha, lamivudine, adefovir, entacavir, telbivudine, tenofovir and emtricitabine are 
approved for treatment. The aim is to achieve a consistent suppression of viral 
replication and disease remission. 
 
Hepatitis B, Hepatitis C and HIV coinfection: 
 The routes of transmission and risk behaviors for HBV and HCV are 
similar to those of HIV transmission. In a study conducted in patients attending 
STD outpatient departments of district hospitals of Northern part of India, it was 
found that HBV/HIV coinfection in 0.2%, and no HIV/HCV coinfection.88  
  
 In a study conducted in STD outpatient department at Jipmer, Pondicherry, 
documents a significant role of sexual route of transmission of HIV,HCV and 
HBV, HIV having the highest risk followed by HCV and HBV. An increased 
incidence of HCV positivity was found in patients with genital ulcer disease and 
HIV infection.  
 
 The male patients with any one of the markers for either anti HBV/anti 
HCV/antiHIV were more likely to have each one of other markers.89 In a 
prospective study conducted in  S.N. Medical College, Uttar Pradesh, India, on 
comparing the HIV and HBV coinfections, the coinfection rates were higher in 
people infected with HIV.90  
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 Persons infected with HIV are at higher risk of acquiring HBV. The 
coinfection of HBV with HIV worsens the prognosis of the liver disease, more 
prone for chronic HBV infection, and also reduces the rate of response to 
interferons. In people infected with HIV and with immunosupression, reactivation 
or reinfection with HBV is common. All patients with HBV infection, should be 
screened for coexistent HIV infection, to decide on treatment options and to 
prevent the emergence of drug resistance.  
 
 The only drugs that can be used as monotherapy in HBV/HIV coinfection 
are adefovir and pegylated interferon.85 Hepatitis C virus causes a rapid 
progression of HIV disease, and HIV coinfection impairs the treatment response 
of HCV. Early diagnosis and appropriate treatment of genital ulcers is essential in 
the prevention of  spread of sexually transmitted diseases. 
Aims and Objectives 
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AIM OF THE STUDY 
 
1. To study about the coincidence of Retroviral disease (HIV), Hepatitis B   
and Hepatitis C in male patients with genital ulcer attending the STD  O.P. 
Institute of Venereology, Government General Hospital. 
2. To study about the association of clinico epidemiological factors with 
Genital Ulcer Disease. 
3. To study about the sexual orientation in patients with Genital Ulcer 
Disease with the coincidence of HIV, Hepatitis B and Hepatitis C. 
4. To determine the commonest causes of Genital Ulcer Disease, coinciding 
with HIV, Hepatitis B and Hepatitis C. 
1. 
Materials and Methods 
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MATERIALS AND METHODS 
 
STUDY DESIGN 
 Prospective study 
 
SAMPLE 
 The study population comprised a total of 100 male patients with genital 
ulcer attending the STD O.P. Institute of Venereology, Government General 
Hospital, Chennai from 1st November 2016 to 31stAugust 2017.  
 
METHODS 
 The patients were interviewed regarding age, educational status, 
occupation, marital status, presenting complaints, sexual history, past history of 
venereal disease and condom usage. 
 
Counseling was given to all patients regarding sexually transmitted disease, 
protective sexual practices, prompt treatment and regular follow up. Pre and post 
test counseling was given. 
 
Complete general examination and genital examination was done for all the 
patients after recording a detailed history. Dark field, tzanck smear, gram stain, 
tissue smear were done in all patients from the genital ulcer to rule out syphilis, 
herpes, chancroid, donovanosis respectively. In addition, wet mount examination 
was done for trichomoniasis and candidiasis. 
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 Serological investigations were done for HIV, HBSAg, anti HCV 
antibodies, VDRL and TPHA tests were done to rule out syphilis. 
 
 Specific investigations like cerebrospinal fluid analysis and CD4 cell count 
were done in patients, if needed. 
 
 Routine baseline laboratory analysis like complete blood count and urine 
routine analysis were done for all patients. Liver and renal function tests, chest X 
ray and ECG were done in the needed patients.  
Observation & Results 
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OBSERVATION AND RESULTS 
AGE DISTRIBUTION OF THE STUDY POPULATION (n=100) 
AGE DISTRIBUTION FREQUENCY PERCENTAGE 
Upto 25 yrs 27 27.0% 
26 - 35 yrs 37 37.0% 
36 - 45 yrs 20 20.0% 
46 - 55 yrs 11 11.0% 
Above 55 yrs 5 5.0% 
Total 100 100.0% 
 
 
 
 
 The most common age group affected with the genital ulcer disease in the 
study population was between 26 - 35 years, and they were 37 in number (37%), 
followed by patients of age less than 25 yrs, who were 27 in number (27%) and 
patients in the age group of 36 - 45 yrs, 20 in number (20%)  patients of 46 - 55 
yrs, 11 in number (11%), and patients above 55 yrs constituted the least, and were 
5 in number (5%). 
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       MARITAL STATUS OF THE STUDY POPULATION (n=100) 
 
MARITAL STATUS FREQUENCY PERCENTAGE 
Unmarried 61 61.0 % 
Married 39 39.0 % 
Total 100 100.0 % 
 
 
 
 Among the 100 patients in the study population (n=100) unmarried patients 
were more commonly affected with the genital ulcer disease, constituting about 61 
in number (61%) as against 39 patients (39%) who were married. 
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CIRCUMCISION STATUS OF THE STUDY POPULATION (n=100) 
CIRCUMCISION 
STATUS FREQUENCY PERCENTAGE. 
Uncircumcised 95 95.0 % 
Circumcised 5 5.0 % 
Total 100 100.0 % 
 
 
 
 
 Among the 100 patients in the study population (n=100) presented 
with genital ulcer disease, 95 patients (95%) were uncircumcised and 5 
patients (5%) were circumcised. 
48 
 
SEXUAL ORIENTATION AMONG THE STUDY POPULATION (n=100) 
SEXUAL  
ORIENTATION FREQUENCY PERCENTAGE 
Heterosexual 64 64.0 % 
Homosexual 22 22.0 % 
Bisexual 14 14.0 % 
Total 100 100.0 % 
 
 
 
Among the 100 patients in the study population (n=100), affected with the 
genital ulcer disease, heterosexual patients were the most common , and were 
about 64 in number (64%), followed by homosexual patients, 22 in number (22%) 
and the least being bisexual patients, 14 in number (14%). 
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SEXUAL ORIENTATION IN PATIENTS WITH GENITAL ULCER       
DISEASE (GUD) POSITIVE FOR RETROVIRAL DISEASE (HIV) 
46.67%
40%
13.33%
Sexual orientation in GUD patients with 
HIV
Heterosexual Homosexual Bisexual
 
SEXUAL 
ORIENTATION FREQUENCY PERCENTAGE 
Heterosexual 7 46.67% 
Homosexual 6 40% 
Bisexual 2 13.33% 
Total 15 100% 
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Among the 15 patients in the study population, who were found to be positive 
for Retroviral disease, 7 patients (46.67%) were found to have heterosexual 
contact, 6 patients (40%) were found to have homosexual contact and 2 patients 
(13.33%) were found to have bisexual contact. 
 
SEXUAL ORIENTATION IN PATIENTS WITH GUD AND POSITIVE 
FOR HEPATITIS B 
SEXUAL 
ORIENTATION FREQUENCY PERCENTAGE 
Homosexual 2 50% 
Heterosexual 1 25% 
Bisexual 1 25% 
Total 4 100% 
 
 
 
 
51 
 
 
 
 
Among the 4 patients who were positive for Hepatitis B in the study 
population, 2 patients (50%) were found to have homosexual contact, 1 patient 
(25%) had heterosexual contact and 1 patient (25%) was found to have bisexual 
contact. 
 
The one patient (1%) positive for Hepatitis C in the study population of 100 
patients (n=100) with genital ulcer, was found to have heterosexual contact. 
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     MODE OF SEX AMONG THE STUDY POPULATION (n=100) 
MODE OF SEX FREQUENCY PERCENTAGE 
Penovaginal 70 70.0 % 
Anoinsertive 18 18.0% 
Anoreceptive 10 10.0 % 
Oroinsertive 1 1.0 % 
Ororeceptive 1 1.0 % 
Total 100 100.0 % 
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 In the study population of 100 patients (n=100), presented with genital 
ulcer disease, penovaginal intercourse was the most common mode of sex, found 
in 70 patients (70%), followed by anoinsertive  intercourse  in 18 patients (18%), 
anoreceptive intercourse in 10 patients (10%), oroinsertive intercourse in 1 patient 
(1%) and ororeceptive intercourse in 1 patient (1%). 
 
CONDOM USAGE IN THE STUDY POPULATION (n=100) 
CONDOM USAGE FREQUENCY PERCENTAGE 
Unprotected 84 84.0 % 
Protected 16 16.0 % 
Total 100 100.0% 
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Among the 100 patients in the study population (n=100), presented with 
genital ulcer disease, 84 patients (84%) followed unprotected sexual intercourse 
and formed a larger group than 16 patients (16%)who followed protective sexual 
practices.  
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NUMBER OF GENITAL ULCERS IN THE STUDY POPULATION 
(n=100) 
NUMBER OF 
GENITAL ULCERS FREQUENCY PERCENTAGE 
Multiple 65 65.0% 
Single 35 35.0% 
Total 100 100.0% 
 
 
 
 
 Among the study population of 100 patients (n=100), 65 patients (65%) 
had multiple ulcers and 35 patients (35%) had single ulcer. 
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ETIOLOGY OF GENITAL ULCER DISEASE IN THE STUDY 
POPULATION (n=100) 
ETIOLOGY FREQUENCY PERCENTAGE 
Venereal 98 98.0% 
Non venereal 2 2.0% 
Total 100 100.0% 
 
 
 Among the 100 patients in the study population,(n=100), who presented 
with genital ulcer disease, 98 patients (98%) had ulcer due to venereal etiology 
and 2 patients (2%) had ulcer due to non venereal cause. 
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VENEREAL CAUSES OF GENITAL ULCER 
VENEREAL CAUSE FREQUENCY PERCENTAGE 
Herpes genitalis 63 64.29% 
Syphilis 35 35.71% 
Total 98 100.0% 
 
 
 Among 98 patients with genital ulcer due to venereal causes, 63 patients 
(64.29%) had ulcer due to herpes genitalis  and 35 patients (35.71%) were found 
to have ulcer due to syphilis.  
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INCIDENCE OF PRIMARY AND SECONDARY SYPHILIS IN GENITAL 
ULCER 
SYPHILIS FREQUENCY PERCENTAGE 
Primary 32 91.43% 
Secondary 3 8.57% 
Total 35 100.0% 
 
 
 Among the 35 patients who had syphilis along with genital ulcer, 32 
patients (91.43%) had ulcer due to primary syphilis and 3 patients(8.57%) had 
features of primary and secondary syphilis. 
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INCIDENCE OF HIV, HEPATITIS B AND HEPATITIS C IN THE STUDY 
POPULATION 
DISEASE FREQUENCY PERCENTAGE 
HIV 15 15.0% 
HEPATITIS B 4 4.0% 
HEPATITIS C 1 1.0% 
 
 Among the 100 patients in the study population (n=100), who presented 
with  genital ulcer, 15 patients (15%) were found to be positive for HIV, 4 
patients (4%) positive for Hepatitis B and 1 patient (1%) was positive for 
Hepatitis C. 
 
INCIDENCE OF SYPHILIS AND HERPES GENITALIS  IN HIV 
POSITIVE PATIENTS 
SYPHILIS/HERPES FREQUENCY PERCENTAGE 
SYPHILIS 8 53.33% 
HERPES GENITALIS 7 46.67% 
TOTAL 15 100.0% 
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 Among the 15 patients with GUD in the study population, who were 
positive for HIV, 8 patients (53.33%) were found to have ulcer due to syphilis and 
7 patients (46.67%) had ulcer due to herpes genitalis. 
 
 None of the patients with genital ulcer due to non venereal cause, had 
positivity for HIV. 
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INCIDENCE OF RETROVIRAL DISEASE IN PATIENTS WITH 
GENITAL ULCER DUE TO SYPHILIS 
 
 In the study population of 100 patients, 35 patients (35%) had GUD due to 
syphilis , 8 patients (22.86%) were found to be positive for Retroviral disease. 
Rest of the 27 patients(77.14%) were HIV negative. Among the 8 HIV positive 
patients, 7 patients (87.5%) had primary syphilis and 1 patient(12.5%) had 
secondary syphilis. 
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INCIDENCE OF RETROVIRAL DISEASE IN PATIENTS WITH 
GENITAL ULCER DUE TO HERPES GENITALIS 
 Among the 100 patients in the study population, 63 patients had ulcer due 
to herpes genitalis. Among the 63 patients , 7 patients (11.11%) were found to be 
positive for Retroviral disease and rest of the 56 patients (88.89%) were negative 
for Retroviral disease . 
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INCIDENCE OF HEPATITIS B IN PATIENTS WITH GENITAL ULCER 
DUE TO SYPHILIS 
 Among the 100 patients who formed the study population(n=100), 35 
patients had genital ulcer due to syphilis. Among the 35 patients , 4 patients 
(11.43%) were found to be positive for Hepatitis B. Rest of the 31 
patients(88.57%)  were negative for Hepatitis B. 
 
 
 Among the 100 patients who formed the study population (n=100), 35 
patients had genital ulcer due to syphilis. Among the 35 patients, 3 patients 
(8.57%) had secondary syphilis . Among the 3 patients, one patient (33.33%) was 
positive for Hepatitis B. 
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 Among the study population of 100 patients with genital ulcer disease, 63 
patients had ulcer due to herpes. None of the 63 patients had positivity for 
Hepatitis B. 
 
 Among the 100 patients(n=100) with genital ulcer disease in our study, 2 
patients(2%) had ulcer due to non venereal cause. Neither of the 2 patients had 
positivity for Hepatitis B. 
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INCIDENCE OF HEPATITIS C IN PATIENTS WITH GENITAL ULCER 
DUE TO SYPHILIS 
 
 Among the 100 patients (n=100) who formed the study population, 35 
patients had genital ulcer due to syphilis. Among the 35 patients (n=35), 1 patient 
(2.86%) was found to be positive for Hepatitis C and rest of the 34 patients 
(97.14%) were negative for Hepatitis C. 
 
 
 
 Among the study population of 100 patients with genital ulcer disease, 63 
patients had ulcer due to herpes. None of the 63 patients had positivity for 
Hepatitis C. 
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 Among 100 patients with genital ulcer disease, 2 patients had ulcer due to 
non venereal cause. Neither of the 2 patients had positivity for Hepatitis C. 
 
COINCIDENCE OF HIV, HEPATITIS B AND HEPATITIS C IN THE 
STUDY POPULATION WITH GENITAL ULCER DUE TO SYPHILIS. 
 Among the 100 patients who presented with genital ulcer, 35 patients had 
genital ulcer due to syphilis, and among the 35 patients one patient (2.86%) had 
positivity for all the three viruses- HIV, Hepatitis B and Hepatitis C. 
 
 Though Herpes  genitalis, constituted the major cause of ulcer disease 
(63%) among the study population of 100 patients, none of the patients had a 
coincidence of all three viruses. 
 
 Among the 100 patients of the study population with genital ulcer disease, 
2 patients (2 %) had ulcer due to non venereal causes. Neither of the two patients 
showed reactivity for any of the three viruses – HIV, Hepatitis B or Hepatitis C. 
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COINCIDENCE OF HIV AND HEPATITIS B IN THE STUDY 
POPULATION (n=100). 
 Among the 100 patients who formed the study population (n=100), 
coincidence of Hepatitis B and HIV was seen in 1 patient (1%). 
 
COINCIDENCE OF HIV AND HEPATITIS C IN THE STUDY 
POPULATION (n=100). 
 Among the 100 patients who formed the study population (n=100), 
coincidence of  Hepatitis C and HIV was seen in 1 patient (1%). 
 
COINCIDENCE OF HEPATITIS B AND HEPATITIS C IN THE STUDY 
POPULATION (n=100). 
 Among the 100 patients who formed the study population (n=100), 
coincidence of Hepatitis B and Hepatitis C was seen in 1 patient (1%). 
 
COINCIDENCE OF HIV, HEPATITIS B AND HEPATITIS C IN THE 
STUDY POPULATION (n=100). 
 Among the 100 patients who formed the study population (n=100), 
coincidence of  HIV, Hepatitis B and Hepatitis C was seen in 1 patient (1%). 
 
  
 
 
 
 
A single well defined ulcer of size 0.5*0.5 cm over the glans penis 
  
  
 
 
 
 
Single, well defined, ulcer, with indurated base present   
circumferentially over the prepuce 
  
  
 
 
 
 
Single well defined ulcer with indurated base present over the coronal sulcus 
  
  
 
 
 
 
Multiple well defined superficial ulcers over the glans penis and prepuce 
 
Discussion 
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DISCUSSION 
 
 The most common age group affected with the genital ulcer disease in 
the study population was between 26 - 35 years, similar to the age 
distribution in the study by Sirisha Singh et al., in a Jipmer study89, and they 
were 37 in number (37%), followed by patients of age less than 25 yrs, 27 in 
number (27%)  and patients above 55 yrs constituted the least, and were 5 in 
number (5%).  
 
 Unmarried patients (61%) were more commonly affected with the 
genital ulcer disease, and 39 patients (39%) were married. 
 
 Among the 100 patients, 95 patients (95%) were uncircumcised and 
only 5 patients (5%) were circumcised. 
 
 Patients were mostly, heterosexuals forming 64%, followed by 22%  
homosexual patients and the least formed by bisexual patients, of about 
(14%). Among the 15 HIV positive patients in the study population, 
7 (46.67%)  had heterosexual contact, 6 patients (40%) had homosexual 
contact and 2 patients (13.33%) had bisexual contact. 
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 Among the 4 patients positive for Hepatitis B, 2 patients (50%) had 
homosexual contact, 1 patient (25%) had heterosexual contact and 1 patient 
(25%) had bisexual contact.  
 
 The one patient (1%) positive for Hepatitis C, was found to have 
heterosexual contact. 
 
 The most common mode of sex was penovaginal intercourse forming 
70%, followed by anoinsertive intercourse in 18%, anoreceptive intercourse 
in 10%, oroinsertive intercourse and ororeceptive intercourse in 1% each.  
 
 Most of the patients(84%) with genital ulcer practiced unprotected 
sexual intercourse and 16% practised protective sex. 
 
 About 65% of patients had multiple ulcers and single ulcer was found 
in   35% patients. 
 
 Venereal etiology was found to be the commonest cause of genital 
ulcer  about 98 patients(98%) and 2% patients had ulcer due to non venereal 
etiology.  
 
 Among 98 patients with venereal cause of genital ulcer, 63 patients 
(64.29%) were found to have herpes genitalis and 35 patients (35.71%) had 
ulcer due to syphilis. 
70 
 
 
       Among the 35 patients with genital ulcer due to syphilis, 32 patients 
(91.43%) had primary syphilis and 3 patients (8.57%) had primary and 
secondary syphilis.  
 
 Among the 100 patients in the study population, HIV was positive in 
15% patients. This is very high compared to the incidence of 2.9% reported 
in a study in South Africa by G Paz Bailey91 et al.,and lower than the 
incidence of 23.2% reported by Sirisha Singh et al, in a JIPMER study.89 
 
 In the study population, 4% patients had Hepatitis B which is lower 
than the incidence of 10 % reported in JIPMER study by Sirisha Singh89 et 
al, and lower than the Tungatkar92 et al., study in Pune in STD patients  with 
the reported incidence of 5.78%.  
 
 Among the study population, 1% patients had hepatitis C. This is very 
low compared to 21.1% incidence reported in JIPMER study by Sirisha 
Singh89 reported in the Tungatkar et al., study92 in Pune in STD patients. 
 
 Among the 15 patients who were positive for HIV, 8 patients 
(53.33%) had  ulcer due to syphilis and 7 patients (46.67%) had herpetic 
ulcers. 
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 Neither of the 2 patients with ulcer due to non venereal etiology, had 
positivity for HIV. 
 
 Among the 35 patients (35%) who had GUD due to syphilis , 8 
patients (22.86%) were positive for Retroviral disease. The remaining 27 
patients (77.14%) were negative for Retroviral disease. 7 (87.5%) among 
the 8 HIV positive patients, had primary syphilis and 1 patient(12.5%) had 
secondary syphilis.  
 
 Out of the 63 patients who had ulcer due to herpes genitalis, 7 
patients (11.11%) were positive for Retroviral disease and the remaining 56 
patients (88.89%) were negative for Retroviral disease. 
 
 Among the 35 patients who had genital ulcer due to syphilis, 4 
patients (11.43%) had Hepatitis B.  
 
 Among the 35 patients who had genital ulcer due to syphilis , 3 
patients (8.57%) had secondary syphilis . Among the 3 patients, one patient 
(33.33%) was positive for Hepatitis B.  
 
 Out of the 63 patients with herpetic ulcers, none had positivity for 
Hepatitis B.  
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 Neither of the 2 patients with non venereal ulcers had positivity for 
Hepatitis B.  
 
 Among the 35 patients with syphilis with genital ulcer, 1 patient 
(2.86%) had positivity for Hepatitis C.  
 
 None among the 63 patients who had herpetic ulcers, showed 
positivity for Hepatitis C.  
 
 Neither of the 2 patients with ulcers due to non venereal etiology had 
Hepatitis C.  
 
 Among the 35 patients with genital ulcer and syphilis, one patient 
(2.86%) had positivity for HIV, Hepatitis B and Hepatitis C.  
 
 Herpes constituted the major cause of genital ulcer disease among the 
study population of about 63% , yet none had a coincidence of all three 
viruses- HIV, Hepatitis B and Hepatitis C.  
 
 Neither of the two patients with non venereal ulcer showed reactivity 
for  HIV, Hepatitis B or Hepatitis C.  
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 Coincidence of HIV and Hepatitis B was seen in one patient (1%) 
which is lower than the result of 9 % coinfection reported in a study 
conducted in South India by Shanmugam Saravanan93 et al.,and slightly 
higher than the coinfection reported in Amristar study by Neerja Jindal94 et 
al., of 2 %. 
 
 Coincidence of  HIV and Hepatitis C was found in 1 patient (1%), 
which is lower than the coinfection of 2.2 % reported  in a study conducted 
in South India by Shanmugam Saravanan93 et al.,and comparable to the 
0.85% reported in an Amristar study by Neerja Jindal94 et al.,   
 
 Coincidence of Hepatitis B and Hepatitis C was present in 1 patient 
(1%).  
 
 Coincidence of HIV, Hepatitis B and Hepatitis C was seen in  
1 patient (1%). No coinfection of the three diseases were found in Amristar 
study94 by Neerja Jindal et al.,among STD clinic attendees. 
Conclusion 
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CONCLUSION 
  The Genital ulcers, commonly occurring due to herpes genitalis and 
syphilis are of public health importance, since there is an increased risk of 
transmitting and acquiring the coinfections like HIV, Hepatitis B and 
Hepatitis C. Early screening, prompt and appropriate management of genital 
ulcers may reduce the further transmission of the coinfection. All the sexual 
partners of the patients should be thoroughly examined, investigated and 
promptly treated. In addition, safe sex practices like consistent and correct 
condom usage should be promoted. Preventive vaccination, as in case of 
Hepatitis B should b considered in all patients with high risk sexual 
behavior. In our study, the increased coincidence of HIV and the 
coinfections like Hepatitis B and Hepatitis C are observed in patients 
suffering from Syphilis, stressing the significance of mandatory screening 
for all the three viruses in all patients with genital ulcers and especially in 
those due to Syphilis.  
Summary 
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SUMMARY 
 The most common age group affected with genital ulcer disease was  
26-35 years -37%. 
 Majority of the patients were unmarried – 61% 
 95% patients were uncircumcised. 
 Heterosexual contact was most common – 64% 
 Penovaginal intercourse was most common mode of sex – 70%. 
 84% patients had unprotected sexual intercourse. 
 65% patients presented with multiple ulcers. 
 98% patients had genital ulcers due to venereal etiology. 
 Herpes genitalis was the most common cause of genital ulcers – 64.29%. 
 Incidence of HIV was 15% and Hepatitis B was 4% and Hepatitis C was 
1%. 
 Coincidence of HIV, Hepatitis B and Hepatitis C in the study population 
with genital ulcer is 1%. 
Bibliography 
  
BIBLIOGRAPHY 
 
1. Hoffman IF, Schmitz J.Genital ulcer disease - Management in the HIV era. 
Post Graduate Med 1995;98:67-82  
2. Vinod K Sharma, Uttam kumar. Clinical Approach To Genital Ulcer 
Disease. Sexually transmitted diseases and HIV/AIDS. Second  edition. 
768,769. 
3. Schmid GP. Approach to the patient with genital ulcer disease. Med Clin 
North Am 1990; 74; 1559-72 
4. Kumar B Handa S, Malhotra S. Changing trends in sexually           
transmitted diseases. Indian J Sex Trans Dis 1995; 16; 24-7 
5. Khanna N, Pandhi RK, Lakhanpal S, Changing trends in sexually 
transmitted diseases:  A hospital based study. Indian J Sex Trans Dis 1996; 
17; 79-81  
6. Sahni AK , Prasad VV, Seth P. Genomic diversity of human        
immunodeficiency virus type-1 in India. Int J STDs AIDS. 2002; 115-8.  
7. Chapel TA, Brown WJ, Jeffres C,et al. How reliable is the       
morphological   diagnosis of penile ulceration? Sex Transm Dis 1977; 4: 
150-2. 
8. Engelkens HJ,Stoltz E.Genital ulcer disease. Int J dermatol 1993;        
32:169-76. 
9. Sunil K Arora, R.S. Paranjape, Srikanth Tripathy, Ajay Wanchu., Human 
Immunodeficiency Virus: Biology and Natural History of Infection. 
Sexually Transmitted Infections, 2 nd edition, 779-791. 
10. Francis Ndowa, Fatim Cham, Sibongile Dludlu. Genital ulcer-Adenopathy  
Syndrome .Sexually Transmitted Infections. Second  Edition, 648 
11. Wasserheit JN. Epidemiological synergy. Interrelationships between 
human immunodeficiency virus infection and other sexually transmitted 
diseases. Sex Transmit Dis. 1992; 19;61-77 
12. Cohen MS. Sexually transmitted diseases enhance HIV transmission: a  
hypothesis no longer. Lancet1998; 351(suppl iii):5-7 
13. Wasserheit JN. Epidemiological synergy: interrelationships between 
human immunodeficiency virus infection and other sexually transmitted 
diseases. Sex Transm Dis 1992; 19:61-77. 
14. Fleming DT, Wasserheit JN. From epidemiological synergy to public 
health  policy and practice; the contribution of other sexually transmitted 
diseases to sexual transmission of HIV infection. Sex Trasm Inf 1999; 75: 
3-17  
15. H K kar , Interaction of human immunodeficiency virus and sexually  
transmitted diseases, Sexually Transmitted Diseases and HIV/AIDS, 
second  edition ;220-235.  
16. Kar HK, Jain RK, Sharma PK, et al . Increasing HIV prevalence in STDs 
clinic attendees in Delhi, India: 6 year (1995-2000) hospital based study 
results. Sex Transm Inf 2001; 77: 393 
17. Kumar B, Gupta S Rising HIV prevalence in STD clinic attendees at 
Chandigarh (North India)- A relatively low prevalence area. Sex Transm 
Inf  2000; 76: 59. 
18. Ray K, Bala M Gupta SM, et al . Changing trends in sexually transmitted  
infections at a Regional STD Centre in North India. Indian J Med 
Res,2006; 124: 559-68. 
19. Subramanian, Gupta MD, Mathai AK, et al. Factors associated with HIV 
seroprevalence among STD patients attending a Govt. STDs clinic in 
Chennai  South India. Indian J Sex Transm Dis 2006; 27: 50-3 
20. Risbud A. Human immunodeficiency virus (HIV) and sexually transmitted   
diseases (STDs). Indian J Med Res. 2005; 121: 369-76  
21. Dimie Ogoina , Haruna M Muktar, Reginald O Obiako, peculiarities of 
genital ulcer diseases in HIV infected patients: report of four cases from 
Zaria,Nigeria, Annals of African Medicine 2011;vol 10:issue 2: 192-193. 
22. Joseph A Sundharam.Herpes Genitalis. Sexually transmitted diseases and 
HIV/AIDS.Second  edition.414,421. 
23. Raj Patel, Sangeetha Sundaram,Bushan Kumar.Genital Herpes         
Simplex  Infections. Sexually Transmitted Infections. Second edition.335-
351. 
24. Mertz GJ, Benedetti J, Ashley R, et al. Risk factors for the sexual  
transmission of genital herpes. Ann Intern Med. 1992; 116: 197-202. 
25. Johnson R, Leef, Hadgu A,et al. Genital herpes trends during the       First 
decade of AIDS:Prevalence increased in young whites and elevated in 
blacks.10 th International Meeting of the Int Soc for STDs Res 1993 
Helsinki(Abstract) 
26. Norris SA, Kessler HA, Fife KH.Severe progressive herpetic         whitlow 
caused  by an acyclovir resistant virus in a patient with         AIDS. J Infect 
dis 1987;157;209-210. 
27. Safrin S,Asseykeen T, Follansby ,et al. Foscarnet therapy for        acyclovir  
resistant mucocutaneous herpes simplex virus in 26 AIDS patients. J Infect 
Dis 1990; 161;  1078-84. 
28. Heng M  Heng S, Allen S. Coinfection and synergy of human 
immunodeficiency virus-1. Lancet 1994; 343;255-8.  
29. Posavad CM, Wald A, Kuntz S et al .Frequent reactivation of  herpes 
simplex virus among HIV-1 infected patients with highly active 
antiretroviral therapy. J Infect Dis 2004; 190: 693-6  
30. Ashly RL. Genital Herpes: Type specific antibodies for the  diagnosis and 
management. Dermatol Clin 1998; 16: 789-93 
31. Goldman BD . Herpes serology for Dermatologist. Arch Dermatol 2000; 
136: 1158-61. 
32. Burrows J, Nitsche A, bayly B, et al. Detection and subtyping of  Herpes  
Simplex virus in clinical samples by Light Cycler PCR, enzyme 
immunoassay  and cell culture. BMC Microbiol 2002; 2: 2-12.  
33. Aldea C, Alvarez CP, Folgueira L, et al. Rapid detection of herpes simplex 
virus DNA in genital ulcers by real time PCR using SYBR green I dye as 
the  detection signal. J Clin Microbiol 2002; 40: 1060-2. 
34. Van Doornum GJ, Guldemeester J, Osterhaus AD, et al . Diagnosing  
herpes virus infections by real time amplification and rapid culture. J Clin  
Microbiol 2003; 41: 576-80. 
35. Rottingen JA, Cameron DW, Garnett GP, A systematic review of the 
epidemiological interactions between classic sexually transmitted diseases 
and HIV: how much is really known? Sex Transmit Dis 2001;28;579-97. 
36. Chung KY, Kim KS, Lee MG, et al., Treponema pallidum induces  
upregulation of interstitial collagenase in human dermal fibroblasts. Acta 
Derm Venereol 2002;82:174-8. 
37. R S Misra, Joginder Kumar, Syphilis: clinical features and natural course. 
Sexually transmitted diseases and HIV/AIDS.Second  edition.page 262-
288. 
38. Brusgaard E. Oeber das schicksal der nicht specifisch behandeltan luetiker. 
Arch Dermatol Syph (Berlin) 1929; 13:234-42. 
39. Centers for Disease Control and Prevention. CDC STD Guidelines 2010. 
Available at www.cdc.gov/std/treatment/ Accessed on August , 26, 2011. 
40. Hook EW 3rd, Marra CM. Acquired syphilis in adults. N Engl  Med 
1992;32;1660-1669. 
41. Palacios R,Jimenez-Onate F, Aguilar , et al. Impact of syphilis infection on 
HIV viral load and CD4 cell counts in HIV infected patients. J Acquire  
immune Deficienc Syndr 2007;44;356-9 
42. Kofoed K, Gerstoft J, Mathiesen LR, Benfield T Syphilis and human 
immunodeficiency virus (HIV)-1 coinfection; influence on CD4 T cell 
count, HIV-1 viral load, and treatment response. Sex Transm Dis 
2006:143-8 
43. Jin F, Prestage GP, Zablotska I, et al. Highnincidence of syphilis in HIV-  
positive homosexual men: data from two community based cohort studies .  
Sex Health 2009;6:281-4 
44. Patrick French,Somesh Gupta,Bhushan Kumar. Infectious Syphilis. 
Sexually Transmitted Infections.Second edition.429-442.  
45. Nnoruku EN, Ezepke A. Evaluation of syphilis in patients with HIV 
infection  in Nigeria. Trop Med Int Health 2005; 10: 58-64. 
46. Rompalo AM, Lawlor J, Seaman P, et al. Modification of syphilis genital  
ulcer manifestations by coexistent HIV infection. Sex Transm Dis  
2001;28:448-54. 
47. Schofer H, Imhof M, Thoma-Greber E,et al. Active syphilis in HIV 
infection:  A multicentre retrospective survey. Genitourin Med 
1996;72:176 
48. Hutchinson C, Hook EW, Shepard M, et al. Altered clinical presentation of  
early syphilis in patients with HIV infection. Ann Intern Med 1994; 121:94 
49. Schofer H, Imhof M, Thoma-Greber E, et al. Active syphilis in HIV 
infection: a multicentre retrospective survey, the German AIDS study 
group. Genitourin Med 1996;72;;176-81. 
50. Czelusta A, Yen-Moore A, Van der Straten M, et al., An overview of 
sexually  transmitted diseases. Part III. Sexually transmitted diseases in 
HIV infected patients. J Am Acad Dermatol 2000;;43:409-32. 
51. Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities  
in patients with  syphilis association with clinical and laboratory features. J 
Infect Dis 2004;180:369-76. 
52. Bondon J, Martinez-Vazquez C,de la Fuente-Aguado J,et al.  Response to 
standard syphilis treatment in patients infected with the human  
immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1999;18:729-32. 
53. Orle KA, Gates CA, Martin DH, et al. Simultaneous PCR detection of  
Haemophilus ducreyi, Treponema pallidum and Herpes simplex virus types 
1 and 2 from genital ulcers. J Clin Microbiol 1996;34:49. 
54. Rosen T, Brown TJ. Genital ulcers evaluation and treatment.  Dermatol 
Clin 1998; 16:673-85 
55. Bilgeri YR, Ballard RC, Duncan MO, et al. Antimicrobial susceptibility of  
103 strains of Haemophilus ducreyi isolated in Johannesberg. Antimicrob  
Agents Chemother 1982; 22: 686-8  
56. Inamadar A.C,Aparna P.Chancroid: an update. Linical Microbiology 
Reviews 1995; 8: 357-75. 
57. Hart G. Venereal disease in a war environment : Incidence and 
management. Med J Aust 1975; 1: 808-10. 
58. Boyd AS. Clinical efficacy of antimicrobial therapy in Haemophilus 
ducreyi  infections. Arch Dermatol 1989; 125:1399-1405. 
59. Charles L.H.Chancroid. National Network of STDs/HIV Prevention 
Training  Centres. 2004:1-8 
60. David L.T. Chancroid and Haemophilus ducreyi: an update. Clinical  
Microbiology Reviews 1995; 8: 357-75. 
61. Plummer FA, Nsanze H, Karasira P et al. Epidemiology of chancroid and  
Haemophilus ducreyi in Nairobi, Kenya. Lancet 1983; 1293-5. 
62. Felman YM, Nikitas JA. Sexually transmitted diseases: update on 
chancroid.  Cutis 1983; 602: 607-8. 
63. Kraus SJ. Kaufman HW, Albritton WL, et al. Chancroid therapy: a review 
of cases confirmed by culture. Rev Infect Dis 1982; 4: S-848-56. 
64. Humphreys TL Schnizlein-Bick CT, Kartz BP, et al .Evolution of the 
cutaneous immune response to experimental Haemophilus ducreyi 
infection and its relevance to HIV-1 acquisition. J Immunol 
2002;169;6316-23 
65. Dallabetta G. HIV and AIDS: how they are linked? Afr Health 1994; 
17:19-20 
66. Laga M Interactions between STDs and HIV infection. STD 212Bulletin 
1992;13:3-6  
67. Magro CM,Crowson AN, Alfa M,et al. A morphological study       of 
penile chancroid lesions in human immunodeficiency virus (HIV) – 
positive and  negative African men with a hypothesis concerning the role 
of chancroid in  HIV transmission. Human Pathol 1996; 27: 1066-70.  
68. Soni Nanda,B.Viswanath Reddy,Bellum Shiva Nagi Reddy.        
Chancroid. Sexually Transmitted Infections.Second edition.529. 
69. Latif AS . Epidemiology control of chancroid, 8th Int Soc STDs         Res 
1989  Copenhagen (Abstr.66) 
70. Draft STD treatment recommendations .National AIDS Control  
organization, Ministry of health and family welfare, Govt of India, New 
Delhi,2005. 
71. Tyndall M, Agoki E, Ombetti J,et al. A randomized, single         blinded 
study of  azithromycin in male patients with culture proven chancroid. 9th 
Int Soc STDs  Res 1991 Banff (Abstr. A-041) 
72. Tyndall M, Malisa M Plummer FA, et al. Ceftrioxone in the        treatment 
of  chancroid. 9th Int Soc STDs Res 1991 Banff (Abstr. A-42) 
73. Stamm WE. Lymphogranuloma venereum. In: Holmes KK,        Sparling 
PF,  Stamn WE,et al.,eds. Sexually Transmitted Diseases        . New York: 
McGraw- Hill, 2008:595-606. 
74. Schachter J. Lymphogranuloma venereum and other non ocular        
Chlamydia  trachomatis infection. In: Hobson, KK, eds.        
Nongonococcal Urethritis and  related infections. Washington:       
American Society of Microbiology,1977:91-7. 
75. Philip RN, Hill DA, Greaves AB,et al. Study of Chlamydiae in       patients 
with  lymphogranuloma venereum and urethritis attending a venereal 
diseases clinic. Br J Vener Dis 1971;47:114-21. 
76. de Vries HJ, Van Der Bij AK, Fennema JS, et al.        lymphogranuloma 
venereum   proctitis in men who have sex with        men is associated with 
anal enema use and  high risk behavior. Sex Transm Dis 2008; 35:203-8. 
77. Van der Bij AK, Spaargaren J, Morre SA, et al. Diagnostic and         
clinical  implications of anorectal lymphogranuloma venereum in men who 
have sex  with men : a retrospective case control study.       Clin Infect Dis 
2006; 42: 186- 94. 
78. Stamm WE, Jones RB, Batteiger BE. Chlamydia  trachomatis (Trachoma, 
Perinatal Infections, Lymphogranuloma venereum, and Other Genital 
Infections).In:Mandel GI,,Bennett JE,Dolin R eds. Principles  and Practice 
of Infectious Diseases 6th ed. London: Elsevier, Churchill, 
Livingstone,2005;2239-55. 
79. Pinsk I Saloojee N, Friedlich M. Lymphogranuloma venereum         as a 
cause of  rectal stricture. Can J Surg 2007;50:E31-E2. 
80. Rosen T, Brown TJ. Cutaneous manifestations of sexually        transmitted  
diseases. Med Clin North Am 1998;82:1081-99. 
81. Mark Bloch, Brian P.Mulhall, Charles Farthing, Richard         Hillman.HIV 
infection in Homosexual Men. . Sexually Transmitted Infections.Second  
edition.1044,1045 
82. Scieux C, Barnes R, Bianchi A, et al. Lymphogranuloma         venereum in 
27 cases in Paris. J Infec Dis 1989; 160: 662-8. 
83. Ronn MM , Ward H. The association between lymphogranuloma venereum  
and HIV among men who have sex with men: systematic review and meta 
analysis. BMC infect Dis 2011;11:70 
84. Gotz HM , van DG , Niesters HG,et al. A cluster of acute         hepatitis c 
virus  infection among men who have sex with men-        results from 
contact tracin and  public health implications. AIDS 2005; 19:969-74  
85. Gary Brook, Yogesh Chawla. Hepatitis viruses. Sexually         Transmitted  
Infections.Second edition.380-395.  
86. Vinod K Sharma ,Manish Bansal. Miscellaneous Sexually         
Transmitted  Diseases. Sexually transmitted diseases and         
HIV/AIDS.Second  edition.457- 485. 
87. Melissa A. Marx, K. G. Murugavel, Patrick M. Tarwater, David L. 
Thomas, Suniti Solomon,David D. Celentano, Association of  Hepatitis C 
Virus Infection with Sexual Exposure in Southern India. , Clin  Infect Dis 
514-520, 15 August 2003. 
88. T.Hussain, K.K.Kulshreshtha, Shika Sinha V.S.Yadav,V.M.Katoch.  HIV,  
HBV, HCV, and syphilis coinfections among patients attending the STD  
clinics of district hospitals in Northern India.International journal of 
Infectious Diseases.september 2006,vol.10(5):358-363.  
89. Sirisha singh, D M Thappa, T J Jaisankar, S Suatha, Department        of 
Dermatology and STD, JIPMER, Pondicherry- 605006, India        Sexual 
co- transmission of HIV, hepatitis B, and hepatitis C viruses ,Sex Transm 
Inf  2000;76:317–318 
90. Arti Agarwal, Ankur Goyal, Sapna Goyal,Sunitha Kumari and     
P.K.Singh , seroprevalence of hepatitis B and syphilis coinfection in HIV 
positive anti retroviral therapy attendees and HIV negative sexually 
transmitted infection attendees, Indian J Sex Transm Dis. 2016 jan-jun; 
37(1): 94-95. 
91. G. Paz Bailey, M. Sternberg, D.A. Lewis, A.Puren, Acute HIV        
Infections among men ith genital ulcer diseases in south Africa. The 
Journal of Infectious Diseases, Volume 201, issue 12, 15 June       2010, 
pages 1811-1815. 
92. Tungatkar SP, Divekar A et al., Exposure of STD patients and        
prisoners from Pune to hepatitis B and C virus. Indian Journal of        
Medical Microbiology. 1997 july; 15(3): 117-9 
93. Shanmugam Saravanan, Vijayakumar Velu, et al., Coinfection of         
Hepatitis B and hepatitis C virus in HIV infected patients in south 
India.www.ncbi.nlm.nih.gov/pmc/articlesPMC4434627 
94. Neeerja Jindal, Usha Arora and Kamldeep singh, Prevalence of         
Human Immunodeficiency virus, hepatitis B virus and Hepatitis C virus in 
three groups of population at high risk of HIV infection in Amristar 
(Punjab), Northern India, J. Infect. Dis., 61, 79-81, 2008. 
  
Annexures 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
  
 
  
  
  
  
CERTIFICATE –II 
 
 
This is to certify that this dissertation work titled “COINCIDENCE OF  
HEPATITIS B, HEPATITIS C AND RETROVIRAL DISEASE WITH 
GENITAL ULCER AMONG MALE PATIENTS ATTENDING STD O.P.” 
of the candidate Dr.V.LAKSHMI PRIYA, with registration Number 201530004 
for the award of M.D DERMATOLOGY, VENEREOLOGY & LEPROSY in 
the branch of XX.  I personally verified the urkund .com website for the purpose 
of plagiarism check. I found that the uploaded thesis file contains from 
introduction to conclusion pages and result shows 1 percentage of plagiarism in 
the dissertation. 
 
 
 
 
                         
Guide & Supervisor sign with Seal 
  
S. No. Age literacy Marital status Sexual orientation Last contact Mode of sex
Number of 
ulcers
Pain Nodes
Tzanck 
smear
Grams stain KOH
Normal 
Saline
VCTC HBS Ag
anti HCV 
ab
VDRL TPHA protection PVD circumcision
1 51 5th married heterosexual 6 months penovaginal single absent present negative pus cells negative pus cells positive negative negative 1:64 reactive positive unprotected absent uncircumcised
2 43 10 th unmarried heterosexual 10 days penovaginal multiple present present negative pus cells negative pus cells negative negative negative non reactive negative unprotected present circumcised
3 36 diploma married heterosexual 4 months penovaginal multiple present present positive pus cells negative pus cells negative negative negative non reactive negative unprotected present uncircumcised
4 27 10 th unmarried homosexual 6 months anoinsertive multiple present absent positive negative negative negative negative negative negative non reactive negative unprotected present uncircumcised
5 30 degree unmarried homosexual 3 months oroinsertive single absent absent negative pus cells negative pus cells negative negative negative non reactive negative unprotected absent uncircumcised
6 29 BSc unmarried heterosexual 2 months penovaginal multiple absent absent negative pus cells negative pus cells negative negative negative non reactive negative unprotected absent uncircumcised
7 28 8 th unmarried bisexual 1 month penovaginal multiple absent absent positive pus cells negative pus cells negative negative negative 1:64 reactive positive unprotected absent circumcised
8 18 BBA unmarried homosexual 2 months anoinsertive multiple absent absent negative negative negative negative negative positive negative 1:64 reactive positive unprotected absent uncircumcised
9 37 IT married bisexual 1 month penovaginal single present present negative negative negative negative positive negative negative 1:128 reactive positive unprotected absent uncircumcised
10 40 8 th unmarried heterosexual 6 days penovaginal multiple present absent negative negative negative negative negative negative negative non reactive negative unprotected present uncircumcised
11 30 12 th unmarried bisexual 6 months penovaginal multiple present present negative pus cells negative negative positive negative negative 1:64 reactive positive unprotected absent uncircumcised
12 38 degree married bisexual 1 month ororecptive multiple absent absent positive negative negative negative positive negative negative non reactive negative unprotected present uncircumcised
13 49 diploma married heterosexual 1 month penovaginal multiple absent absent negative negative negative negative negative negative negative non reactive negative unprotected present uncircumcised
14 30 illiterate unmarried heterosexual 6 months penovaginal single absent absent negative
epithelial 
cells
negative negative negative negative negative non reactive negative unprotected absent uncircumcised
15 28 illiterate unmarried bisexual 20 days oroinsertive multiple present present negative negative negative negative negative negative negative 1:16 reactive positive unprotected present uncircumcised
16 34 ug married heterosexual 3 months penovaginal multiple absent present negative pus cells negative pus cells negative negative negative 1:64 reactive positive unprotected absent uncircumcised
17 22 ug unmarried heterosexual 1 week penovaginal single absent absent negative negative negative negative negative negative negative 1:2 reactive positive unprotected present uncircumcised
18 33 degree married bisexual 4 weeks oroinsertive single present absent negative negative negative negative negative negative negative 1:8 reactive positive unprotected absent uncircumcised
19 20 ug unmarried heterosexual 45 days penovaginal single absent absent negative pus cells negative negative negative positive negative 1:64 reactive positive unprotected present uncircumcised
20 29 degree unmarried heterosexual 2 years penovaginal multiple present present negative pus cells negative negative negative negative negative non reactive negative protected present uncircumcised
21 36 degree married heterosexual 5 months penovaginal multiple absent absent positive negative negative negative negative negative negative non reactive negative protected present uncircumcised
22 23 10 th unmarried heterosexual 1 month penovaginal multiple absent present negative negative negative negative negative negative negative 1:32 reactive positive unprotected absent uncircumcised
23 47 illiterate married heterosexual 1 week penovaginal single present present negative pus cells negative pus cells positive negative negative non reactive negative unprotected absent uncircumcised
24 48 illiterate married bisexual 1 month anoinsertive multiple absent present negative negative negative negative negative negative negative 1:64 reactive positive unprotected absent uncircumcised
25 26 12 th unmarried heterosexual 1 month penovaginal multiple present present negative negative negative negative negative negative negative non reactive negative protected absent uncircumcised
26 31 degree married heterosexual 1 week penovaginal single present present negative pus cells negative pus cells negative negative negative non reactive negative unprotected absent uncircumcised
27 51 illiterate married heterosexual 8 yrs penovaginal single present absent negative pus cells negative pus cells positive negative negative non reactive negative unprotected present uncircumcised
28 26 diploma married heterosexual 2 weeks penovaginal single absent absent negative pus cells negative pus cells negative negative negative non reactive negative protected present uncircumcised
29 36 12 th married heterosexual 10 days penovaginal multiple present present negative negative negative negative negative negative negative non reactive negative unprotected present uncircumcised
30 24 10 th unmarried heterosexual 6 months penovaginal multiple present absent negative negative negative negative negative negative negative non reactive negative unprotected absent uncircumcised
31 43 8 th married heterosexual 1 week penovaginal single present absent negative pus cells negative pus cells negative negative negative non reactive negative unprotected absent uncircumcised
32 52 8 th unmarried heterosexual 2 weeks penovaginal multiple present absent negative negative negative negative negative negative negative non reactive negative unprotected present uncircumcised
33 35 9 th married heterosexual 1 month penovaginal multiple present absent negative pus cells negative negative negative negative negative non reactive negative unprotected present uncircumcised
34 22 degree unmarried homosexual 6 months anoreceptive single absent present negative pus cells negative pus cells negative positive negative 1:4 reactive positive unprotected present uncircumcised
35 42 6 th married heterosexual 2 months penovaginal multiple absent present positive pus cells negative negative negative negative negative non reactive negative unprotected present uncircumcised
36 29 degree unmarried homosexual 3 weeks anoinsertive multiple present absent negative negative negative negative negative negative negative non reactive negative protected present uncircumcised
MASTER CHART
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ulcers
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37 56 5 th married heterosexual 3 months penovaginal multiple absent present negative pus cells negative pus cells positive negative negative non reactive negative unprotected present uncircumcised
38 25 illiterate unmarried homosexual 1 week anoinsertive multiple present absent negative negative negative negative negative negative negative non reactive negative unprotected absent uncircumcised
39 40 illiterate unmarried homosexual 1 month anoinsertive multiple present absent positive pus cells negative negative negative negative negative non reactive negative unprotected present uncircumcised
40 23 degree unmarried heterosexual 5 days penovaginal single absent absent negative negative negative negative negative negative negative non reactive negative unprotected present uncircumcised
41 33 illiterate unmarried bisexual 20 days anoreceptive single absent present negative pus cells negative pus cells negative negative negative 1:2 reactive positive unprotected present uncircumcised
42 28 degree unmarried homosexual 1 month anoreceptive single absent absent negative negative negative negative negative negative negative non reactive negative unprotected absent uncircumcised
43 25 diploma unmarried homosexual 45 days anoinsertive single absent absent negative negative negative negative negative negative negative 1:128 reactive positive unprotected present uncircumcised
44 32 11 th married heterosexual 2 weeks penovaginal multiple present absent negative negative negative negative negative negative negative non reactive negative protected absent uncircumcised
45 39 degree married heterosexual 5 months penovaginal single absent absent negative negative negative negative positive negative negative non reactive negative unprotected present uncircumcised
46 54 degree married heterosexual 45 days penovaginal multiple absent present negative negative negative negative negative negative negative non reactive negative unprotected present uncircumcised
47 48 diploma married heterosexual 1 year penovaginal multiple present absent positive pus cells negative pus cells positive negative negative 1:8 reactive positive unprotected absent uncircumcised
48 45 5 th married heterosexual 6 months penovaginal single absent absent negative negative negative negative negative negative negative non reactive negative unprotected absent uncircumcised
49 62 illiterate married heterosexual 4 months penovaginal multiple absent absent negative pus cells negative pus cells negative negative negative 1:16 reactive positive unprotected absent uncircumcised
50 20 5 th unmarried homosexual 1 month anoinsertive single present absent negative pus cells negative pus cells negative negative negative non reactive negative unprotected absent uncircumcised
51 28 6 th unmarried homosexual 3 months anoreceptive multiple present absent negative negative negative negative negative negative negative non reactive negative unprotected absent uncircumcised
52 25 degree unmarried heterosexual 2 months penovaginal single present absent negative negative negative negative negative negative negative non reactive negative unprotected present uncircumcised
53 31 degree married bisexual 3 months penovaginal multiple absent absent positive negative negative negative negative negative negative non reactive negative unprotected absent uncircumcised
54 35 degree married heterosexual 1 month penovaginal multiple absent absent negative negative negative negative negative negative negative 1:32 reactive positive unprotected present uncircumcised
55 29 diploma unmarried homosexual 15 days anoreceptive single absent absent negative pus cells negative negative negative negative negative 1:32 reactive positive unprotected present uncircumcised
56 23 9 th unmarried bisexual 10 days anoinsertive multiple present absent negative pus cells negative pus cells positive negative negative 1:64 reactive positive unprotected absent uncircumcised
57 29 10 th unmarried heterosexual 4 days anoinsertive multiple present present negative pus cells negative negative positive positive positive 1:16 reactive positive unprotected present uncircumcised
58 26 5 th married bisexual 1 week penovaginal multiple absent absent negative negative negative negative negative negative negative non reactive negative unprotected absent uncircumcised
59 18 illiterate unmarried heterosexual 2 weeks penovaginal multiple absent absent positive negative negative negative negative negative negative non reactive negative unprotected absent uncircumcised
60 64 illiterate married heterosexual 4 months penovaginal multiple present absent positive negative negative negative negative negative negative non reactive negative unprotected present uncircumcised
61 28 degree unmarried bisexual 2 weeks penovaginal multiple present present pus cells negative negative negative negative negative negative non reactive negative unprotected present uncircumcised
62 26 5 th unmarried heterosexual 2 months penovaginal single absent present negative negative negative negative negative negative negative 1:64 reactive positive unprotected absent uncircumcised
63 26 degree unmarried heterosexual 3 months penovaginal single absent present negative negative negative negative negative negative negative 1:8 reactive positive unprotected present uncircumcised
64 60 5 th married heterosexual 5 yrs penovaginal multiple present present negative pus cells negative pus cells negative negative negative 1:16 reactive positive unprotected present uncircumcised
65 30 6 th unmarried heterosexual 2 months penovaginal single absent absent negative pus cells negative pus cells positive negative negative non reactive negative unprotected absent uncircumcised
66 28 degree unmarried heterosexual 3 months penovaginal multiple present absent pus cells negative negative negative negative negative negative non reactive negative unprotected absent uncircumcised
67 36 diploma unmarried heterosexual 4 months penovaginal multiple absent absent negative negative negative negative negative negative negative non reactive negative unprotected absent uncircumcised
68 25 degree unmarried heterosexual 3 months penovaginal single absent present negative pus cells negative pus cells negative negative negative 1:128 reactive positive unprotected present uncircumcised
69 33 degree unmarried homosexual 15 days anorecptive multiple present present positive pus cells negative pus cells negative negative negative non reactive negative protected present uncircumcised
70 40 degree married heterosexual 15 days penovaginal multiple present absent negative pus cells negative negative negative negative Negative non reactive negative unprotected present circumcised
71 38 degree unmarried heterosexual I month penovaginal multiple present present positive pus cells negative pus cells negative negative negative non reactive negative protected present circumcised
72 65 5 th married heterosexual 3weeks penovaginal multiple present absent negative pus cells negative negative negative negative negative non reactive negative unprotected absent uncircumcised
73 26 degree unmarried bisexual 1 week anoinsertive multiple present present positive pus cells negative pus cells positive negative negative non reactive negative unprotected present uncircumcised
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74 29 10 th unmarried heterosexual 1 month penovaginal multiple present present positive pus cells negative pus cells negative negative negative non reactive negative protected present uncircumcised
75 40 5 th married heterosexual 2 months penovaginal multiple present absent negative pus cells negative pus cells negative negative negative non reactive negative protected present uncircumcised
76 44 illiterate married heterosexual 1 week penovaginal multiple present present positive pus cells negative pus cells negative negative negative non reactive negative protected present uncircumcised
77 22 degree unmarried homosexual 10 days anoinsertive multiple present present positive pus cells negative pus cells negative negative negative non reactive negative protected present uncircumcised
78 44 illiterate married heterosexual 2 weeks penovaginal multiple present absent negative pus cells negative pus cells negative negative negative non reactive negative protected present uncircumcised
79 31 illiterate unmarried heterosexual 1 month penovaginal multiple present present positive pus cells negative pus cells negative negative negative non reactive negative protected present uncircumcised
80 19 ug unmarried homosexual 1 week anoinsertive multiple present present positive pus cells negative pus cells negative negative negative non reactive negative protected absent uncircumcised
81 24 diploma unmarried homosexual 1 month anoinsertive single absent present negative pus cells negative pus cells negative negative negative 1:128 reactive positive unprotected absent uncircumcised
82 48 10 th married bisexual 15 days penovaginal single absent present negative pus cells negative pus cells negative negative negative 1:64 reactive positive unprotected absent uncircumcised
83 23 degree unmarried heterosexual 15 days penovaginal single absent present negative pus cells negative negative negative negative negative 1:16 reactive positive unprotected present uncircumcised
84 26 degree unmarried heterosexual 1 week penovaginal single absent absent negative negative negative pus cells negative negative negative 1:8 reactive positive unprotected present uncircumcised
85 21 5 th unmarried heterosexual 1 month penovaginal single absent present negative pus cells negative negative negative negative negative 1:64 reactive positive unprotected present uncircumcised
86 26 degree unmarried homosexual 2 weeks anoreceptive single absent present negative pus cells negative pus cells positive negative negative 1:64 reactive positive unprotected absent uncircumcised
87 23 degree unmarried homosexual 1 week anoinsertive single absent present negative pus cells negative pus cells positive negative negative 1:64 reactive positive unprotected present uncircumcised
88 44 10 th married heterosexual 2 weeks penovaginal multiple present present positive pus cells negative negative negative negative negative 1:16 reactive positive unprotected present uncircumcised
89 39 7 th married heterosexual 2 weeks penovaginal multiple absent absent positive pus cells negative pus cells negative negative negative non reactive negative unprotected absent uncircumcised
90 26 degree unmarried heterosexual 1 month penovaginal multiple present absent negative pus cells negative negative negative negative negative non reactive negative unprotected present circumcised
91 32 degree unmarried heterosexual 3 months penovaginal multiple present present positive pus cells negative pus cells negative negative negative non reactive negative unprotected absent uncircumcised
92 23 diploma unmarried heterosexual 4 months penovaginal multiple present absent negative pus cells negative pus cells negative negative negative non reactive negative protected present uncircumcised
93 23 degree unmarried heterosexual 1 month penovaginal multiple absent absent negative negative negative pus cells negative negative negative non reactive negative unprotected present uncircumcised
94 23 degree unmarried homosexual 2 months anoinsertive multiple present absent positive negative negative pus cells negative negative negative non reactive negative unprotected absent uncircumcised
95 50 10 th married heterosexual 3months penovaginal multiple present absent positive pus cells negative pus cells negative negative negative non reactive negative unprotected absent uncircumcised
96 23 degree unmarried heterosexual 3  months penovaginal multiple present absent negative pus cells negative pus cells negative negative negative non reactive negative unprotected present uncircumcised
97 25 degree unmarried homosexual 2 months anorecptive single absent present negative pus cells negative pus cells negative negative negative 1:64 reactive positive unprotected present uncircumcised
98 20 12 th unmarried homosexual 10 days anoinsertive multiple present present positive pus cells negative pus cells negative negative negative non reactive negative unprotected present uncircumcised
99 46 10 th married heterosexual 1 month penovaginal multiple present present positive pus cells negative pus cells negative negative negative non reactive negative unprotected present uncircumcised
100 21 illiterate unmarried homosexual 1 week anoinsertive single absent present negative pus cells negative pus cells negative negative negative 1:64 reactive positive unprotected present uncircumcised
 KEY FOR MASTER CHART 
 
1.    KOH       -       Potassium Hydroxide 
2.   VCTC     -       Voluntary Counselling and Testing Center 
3.    HBSAg  -       Hepatitis B Surface Antigen 
4.    VDRL    -       Venereal Disease Research Laboratory 
5.     TPHA    -      Treponema Pallidum Hemagglutination  
6.      PVD      -      Previous Venereal Disease 
 
KEY FOR REVIEW OF LITERATURE 
 
1. AIDS    -   Acquired Immuno Deficiency Syndrome 
2. ART    -    Anti Retroviral Therapy 
3. AST     -     Aspartate Transaminase 
4. ALT    -      Alanine Transaminase 
5. CD      -      Cluster of Differentiation 
6. CNS     -      Central Nervous System 
7. CCR    -      Chemokine CoReceptor 
8. DNA    -      Deoxyribo Nucleic Acid 
9. GIT      -       Gastro Intestinal Tract 
10. GUD    -       Genital Ulcer Disease 
11. HCV    -        Hepatitis C Virus 
12. HBSAg -      Hepatitis B Surface Antigen 
13. HIV       -      Human Immunodeficiency Virus 
14. HAART-      Highly Active Anti Retroviral Therapy 
15. IRIS       -      Immune Reativation Inflammatory Syndrome 
16. LGV      -      Lympho Granuloma Venereum 
17. MSM    -      Men having Sex with Men 
18. NHL    -   Non Hodgkins Lymphoma 
19. NSAID  -  Non Steroidal Anti Inflammatory Drug 
20. PCR      -  Polymerase Chain Reaction 
21. RNA     -   Ribo Nucleic Acid 
22. TB        -    Tuberculosis 
